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ABSTRACT
The tear film is a complex mixture of proteins, mucins and lipids that forms a layer
over the anterior surface of the eye and is vital in ocular health. The outer portion
of the tear film contains a thin lipid layer, which prevents the excess evaporation of
the aqueous phase and aids in the stability of the tear film. The tear film lipid layer
contains both polar and non-polar lipids, with the polar lipids thought to act as a
surfactant that spread the non-polar lipids across the aqueous surface to produce a
stable tear film. Despite the importance of tear film lipids, their complexity and the
small volume of samples collected (of which lipids only comprise a small
proportion) has made identification of the complete tear lipidome difficult. The use
of animal models or analysis of meibomian gland secretions (meibum) – believed
to be the major source of tear lipids – have been utilised in an attempt to overcome
these difficulties, however recent studies suggest their profiles may not be a true
representation of human tear film lipids. The identification of the polar lipidome in
tears and meibum has been particularly controversial. While earlier studies
reported that phospholipids played an important role in this, more recent studies
have failed to detect any significant concentrations of phospholipid. It is this
uncertainty that highlights the need for a more detailed analysis into the lipid
profile, particularly for polar lipids.

Changes in the tear film have been implicated in contact lens spoliation and
intolerance, with tear film components rapidly depositing onto contact lenses
following insertion. Research into the deposition of proteins onto contact lenses
xv

has been extensive, with contact lens material shown to be a factor in protein
deposition.1 Investigations into the deposition of lipids have been more limited,
and many studies using in vitro experiments or the measurement of total lipid only.
Furthermore, there has been little work into the effect of contact lens wear on tear
lipids, which may have implications for contact lens intolerance and contact lens
related dry eye. The aim of this thesis was therefore to provide a detailed analysis
of phospholipids in human basal tears, meibum and deposited onto contact lenses
using electrospray ionisation tandem mass spectrometry.

This thesis established optimised methods for the extraction and analysis of
phospholipids from very small volumes of tears (~5 µL). This was achieved using a
biphasic extraction followed by nano-electrospray ionisation tandem mass
spectrometry. Utilising these methods, the unequivocal presence of phospholipids
in human basal tears could be determined. The identification of individual
molecules in sphingomyelin, phosphatidylcholine, phosphatidylethanolamine and
phosphatidylserine phospholipid classes was established and their concentration
was determined. These same phospholipid classes were identified in human
meibum samples, however comparison of the phospholipid profiles between tears
and meibum showed significant differences, suggesting that meibum may not be
the sole source of phospholipids in tears.

The analysis of in vivo deposition of tear film lipids onto contact lenses confirmed
that tear phospholipids deposit onto contact lenses. The concentration of both

xvi

polar and non-polar lipids deposited was significantly affected by contact lens
material, with a differential efficacy of lens care solutions also observed.

Tear phospholipid levels were affected by contact lens wear, with both short (i.e.,
30 min) and long term (30 days) wear showing significant differences in
phospholipid concentration. While there were no differences between contact lens
materials, significant differences were observed with the combination of lens and
time, but were not consistent across all phospholipids. This is likely due to the
large variability of phospholipid concentrations across samples. The methods
optimised within this thesis would allow for the analysis of the more abundant
lipids, particularly cholesterol esters and the newly characterised (O-acyl)-ωhydroxy fatty acids, which may show more definitive changes with contact lens
wear. This could provide valuable information for research into contact lens
biocompatibility, as well as the changes in tear lipids associated with contact lens
intolerance and dry eye disease.

The concentration of total phospholipid in tears was measured at 17 ± 2 pmol/mg
tear. At these low concentrations, it is unlikely that phospholipids are solely
responsible for spreading of the non-polar lipids across the aqueous phase. If
phospholipids do play a role in spreading of the tear film lipid layer then it is likely
in cooperation with more abundant surfactants such as (O-acyl)-ω-hydroxy fatty
acids, which have garnered much attention recently. The work presented in this
thesis has confirmed that (O-acyl)-ω-hydroxy fatty acids are not only present in
meibum, but also in human tears and deposited onto contact lenses in vivo.
xvii

Furthermore, the comprehensive structural characterisation undertaken shows
that their properties make them ideal candidates to act as a surfactant within the
tear film. This could have major implications for tear film stability, dry eye disease
and contact lens intolerance.

This thesis answers the question over the presence of phospholipids in human
tears, confirming their presence but showing that they are not observed in
concentrations high enough to be the sole surfactant provider in the tear film.
While phospholipids are present in meibum, their profile is different to that of
tears, suggesting that they may not be the sole provider of tear phospholipids.
These tear phospholipids are shown to deposit onto contact lenses, with contact
lens wear affecting the concentration of phospholipids in tears.

xviii
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1 INTRODUCTION
1. 1 Tear film structure and function
The tear film covers the outer mucosal epithelial layers of the eye, the cornea and
conjunctiva. The total thickness of the tear film has been measured between three
and 46 µm.2-7 It is secreted during a blink and spread over the surface of the eye by
the eyelids8 at a rate of approximately 1-2 µL/min.9 Following a blink, there is
drainage of the tear film into the lacrimal sac, and a small amount of evaporation of
the aqueous phase, therefore subsequent blinks are required to maintain the
integrity of the tear film.10

Traditionally, the tear film has been described as having three distinct layers.11 The
inner layer contains highly glycosylated proteins called mucins that form a
hydrophilic covering over the epithelial surface of the cornea.12 This hydrophilic
surface allows the spread of the middle aqueous layer, which contains proteins,
salts and other low molecular weight solutes. The outer layer is made up of both
polar and non-polar lipids which spread across the aqueous phase. In recent years,
this model of the tear film has been challenged, with researchers now suggesting
there exists a greater interaction between the tear film components (Figure 1.1).13
In particular secreted mucins, which are highly soluble, form a gel with the
aqueous phase and its components, while lipids, which spread across the anterior
surface of the tear film, interact with aqueous proteins and the mucin gel to form a
stable tear film.14
1

Figure 1.1: An artistic representation of the tear film, showing anchored mucins
covering the epithelial surface, with free mucins and proteins contained within the
aqueous phase and an outer lipid layer. *Only two layers shown, representing
inner polar and outer non-polar lipids. Adapted from Butovich et al.15

1.1.1 Mucins
Mucins are a complex group of high molecular weight glycoproteins that contain
50-80% carbohydrate by mass that is O-linked to the polypeptide backbone.16 The
high glycosylation of the molecules makes them very wettable. This high water
content allows nutrients and gases (such as oxygen) to pass through and feed the
avascular cornea.9 There have been approximately 20 different mucins identified
in humans and they form two categories; membrane-tethered or secreted mucins.
Of the 20 identified in humans, there have been seven detected in human tears.

2

These are the membrane-tethered mucins MUC1, MUC4 and MUC16, as well as the
secreted mucins MUC2, MUC5AC.16

Membrane-tethered mucins are smaller than secreted mucins.17 Their structure
can be divided into three domains; a hydrophilic membrane-spanning domain, a
large extracellular domain that contains tandem repeats of amino acids rich in
serine and threonine, and a small cytoplasmic tail.13, 17 They have been estimated
to extend 200-500 nm from the epithelial surface17 and form a physical barrier to
protect the surface of the eye.18 Their other important function is to fill in the small
irregularities on the epithelial surface, thus providing a smooth surface for optimal
visual acuity.9

Secreted mucins originate from goblet cells and may be classified as gel-forming or
soluble. Gel-forming mucins are capable of forming viscoelastic gels by disulphide
linkage between molecules. They provide lubrication to the eye, preventing
shearing of the epithelial surface by the eyelids,19 and lower the surface tension of
the tear film.20

1.1.2 Aqueous phase
The aqueous phase is primarily secreted by the lacrimal gland and its accessory
glands and is made up of approximately 98% water.20 It contains a number of
solutes, including electrolytes, the most abundant of which is Na+ at a
concentration of 129 mM. Other ions present include Cl-, HCO3-, Mg2+, K+ and Ca2+,
3

with organic solutes such as urea, lactate, glucose, pyruvate, ascorbate and retinol
also observed.20 Tear film electrolytes are important in the maintenance of the
integrity of the epithelium and tear osmolarity.9 The latter is very stable over the
course of the day, only lowering during sleep where there is little evaporation.21
For basal (unstimulated) tears, the osmolarity has been measured at 302 ± 6
mOsm/L.22

The aqueous phase contains a large number of proteins, with a total concentration
of between 7 - 12 mg/mL.23-26 The four most abundant are lysozyme, lactoferrin,
tear lipocalin and secretory immunoglobulin A (sIgA), each accounting for 15-20%
of total protein concentration.18 These proteins play an important role in the
protection of the eye from microbial invasion. Lysozyme is the most abundant,
observed at concentrations of 1.8 – 2.4 mg/mL,18,

24, 27

and is an antibacterial

protein that lyses the cell walls of Gram-positive bacteria.20 Lactoferrin is an irontransport protein which reversibly binds up to two iron atoms.28 In tears, it forms
part of the non-specific defence against microbial invasion by acting as a scavenger
of free iron, thus reducing its availability for microbial metabolism.29 Its
concentration in tears is between 1.5 and 2.2 mg/mL.24, 28 Secretory IgA, which has
a concentration of 0.4 – 0.8 mg/mL tears, further adds to this microbial defence by
inhibiting the adhesion of bacteria to the ocular surface30 and making them a target
for phagocytosis.31

Tear lipocalin is a further important protein identified in tears at concentrations of
~1.5 mg/mL.18, 23 Lipocalins are small extracellular proteins that bind lipids and
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have been implicated in lipid transport.32 Studies have found tear lipocalins bind to
a range of different lipids including fatty acids and fatty alcohols, cholesterol,
phospholipids and glycolipids.33 These proteins may be important in aqueous/lipid
layer interactions and stabilisation of the outer lipid layer.9, 34 They have also been
implicated in the removal of excess lipid from the corneal surface, thus preventing
hydrophobic regions from appearing.35

1.1.3 Lipid layer
The outer lipid component accounts for the smallest fraction of the tear film, but is
still a vital component in tear stability. The primary source of tear film lipids is the
meibomian glands (also known as the tarsal glands), which are sebaceous glands
located on the upper and lower tarsal plates of the eyelids. There are 30 – 40
glands located in the upper lid and 20 – 30 in the lower lid.11 The branched acinar
clusters within the gland each lead to a single duct on the lid margin where the
secretion is released onto the surface of the eye (Figure 1.2). This secretion – often
termed meibum36 – is released from the secretory cells by a holocrine mechanism,
in which the cell ruptures and both the cell and its contents are released into the
duct.
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A

B

Figure 1.2: A) Schematic representation of meibomian gland, with acini leading to a
central duct for secretion.37 B) Infrared photograph of the inside of the eyelid
showing the meibomian glands (white lines). Photo courtesy of Brien Holden
Vision Institute.

Meibum is composed primarily of lipids and has a melting temperature range of 19
– 40 oC,38-41 which is important if it is to remain a fluid at physiological
temperatures. It is released from the ducts and spread across the eye by a blink
where it forms the outer lipid layer.42-43 The lipids are believed to form a bi-layer,
with the polar lipids interacting with the aqueous phase and allowing the spread of
the non-polar lipids across the outer surface.44-45 It has been measured at between
13 - 100 nm thick,46-49 with a recent study by King-Smith et al. using spectral
interferometry giving an average lipid layer thickness of 42 nm.50 Given that the
length of an average lipid is approximately 22 Å (2.2 nm), this equates to a lipid
layer approximately 20 molecules thick, with polar lipids probably accounting for
only 1 – 3 layers.51-52
6

The tear film lipid layer forms over the aqueous component and aids in retarding
evaporation from the ocular surface,53 as well as reducing the tear film surface
tension.54 It provides a barrier to prevent basal tears from spilling over the lid
margin, at the same time precluding the migration of hydrophobic skin lipids onto
the ocular surface.55 It provides a smooth optical surface which is paramount for
good visual acuity.52 Furthermore, it plays a role in the regulation of carbon
dioxide and oxygen exchange.44

Lipids are an essential part of the tear film, which is a complex and well balanced
environment.14 Changes in the content or volume of basal tear production can lead
to instability and the occurrence of dry eye disease. Tear lipids will be discussed in
further detail in Section 1. 3.

1. 2 Pathologies of dry eye
Dry eye disease is one of the most common ophthalmic problems observed by
clinicians, with close to 5 million people over the age of fifty diagnosed as having
moderate to severe dry eye disease in the U.S. alone.56 This incidence is set to
increase in coming years due to population aging in developed countries.57 The
term dry eye encompasses many different pathologies. The flow chart in Figure 1.3
was developed by the International Dry Eye Workshop (DEWS) in 2007, where
they defined dry eye as:
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“a multifactorial disease of the tears and ocular surface that results in
symptoms of discomfort, visual disturbance, and tear film instability with
potential damage to the ocular surface.”58

Figure 1.3: Flow chart of the major dry eye pathologies, as determined by the
International Dry Eye Workshop in 2007.58

Dry eye can be broadly grouped as either aqueous-deficient or evaporative. As the
name suggests, aqueous-deficient dry eye refers to a pathology where there is
insufficient aqueous fluid produced by the lacrimal glands resulting in a decrease
in tear volume. Aqueous-deficient dry eye is further divided into Sjogren’s
syndrome or non-Sjogren’s syndrome. Sjogren’s syndrome is an autoimmune
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disease characterised by the inability to produce tears or saliva or dryness of other
mucus membranes. This may occur alone (primary) or together with other
autoimmune diseases (secondary). Non-Sjogren’s syndrome includes all other
forms of aqueous-deficient dry eye pathologies, including obstruction of the
lacrimal gland ducts, ocular sensory loss and the use of some systemic drugs.

Evaporative dry eye refers to pathologies in which the aqueous component of the
tear film evaporates at an accelerated rate. In normal individuals, the tear film
evaporates at a rate of 0.14 ± 0.06 µL/min. For patients suffering evaporative dry
eye, this rate is significantly increased to 0.43 ± 0.19 µL/min.59 Evaporative dry
eye can be divided into evaporation caused by extrinsic factors and that caused by
intrinsic factors. Extrinsic factors include ocular surface diseases and contact lens
wear, with some studies finding that dry eye occurrence is greater in contact lens
wearers than non-wearers.60-61 Approximately 50% of contact lens wearers have
reported symptoms of dry eye disease,60, 62 with one study reporting that 34% of
contact lens wearers ceased use at least once within 5 years of fitting due to
dryness and discomfort.63

Meibomian gland dysfunction (MGD) is the most common intrinsic factor in
evaporative dry eye disease.58 It can exist alone or be associated with other
diseases, such as seborrheic dermatitis or anterior blepharitis. MGD is
characterised by abnormal meibomian glands, which may exhibit obstruction of
the ducts by cellular debris and/or the presence of a thickened, stagnated meibum
that may alter the lipid component of the tear film.64 The melting temperature of
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meibum is significantly higher with MGD when compared to meibum from control
subjects, with a phase transition temperature of 28.9 ± 0.4 oC observed for normal
individuals and 32.2 ± 0.5 oC for those with MGD.65 This increase has been linked
with changes in the conformation of the hydrocarbon chains.65 Other studies have
implicated changes in the composition of meibum and tear film lipids. This will be
discussed in further detail in Section 1.3.4.

Reduction in tear volume and excess evaporation have both been linked with tear
hyperosmolarity. These changes can initiate a series of inflammatory events on the
ocular surface, causing redness and ocular discomfort, as well as loss of goblet cells
leading to changes in mucin secretion.20 Other symptoms of dry eye include foreign
body sensation, itching, blurred vision due to the instability of the tear film66-67
and, in more severe cases, corneal damage due to epithelial shearing.68

Analysis of the tear film has been difficult to achieve due to the small sample size,
the large variation between individual patients, differences in methods of
collection, and diurnal variation.20 There are many tests that can be used to
diagnose and monitor dry eye disease, including ocular surface staining and tear
physiology tests, however there is no single standardised test and in many cases
the exact aetiology is not pinpointed. In most cases, a series of investigations are
undertaken by the clinician, which generally begins with a validated dry eye
symptoms questionnaire.66 Clinical tests include non-invasive tear break up time
(TBUT), which is used to examine the time it takes the tear film to thin between
blinks.69 In a healthy person, the TBUT is 10 seconds or more, whereas for a dry
10

eye patient this is less than six seconds.69-70 A Schirmer test is used to measure the
tear volume. This invasive test involves placing a strip of filter paper on the lower
margin of the lid and measuring the distance the tears have absorbed over a given
time period. A wetting of greater than 20 mm of filter paper in a five minute period
is considered normal, while measurements of less than 5 mm indicate dry eye.71
Alternatively, the phenol red thread test is quicker and more comfortable than the
Schirmer test. In this test, a commercially available thread is placed into the
palbebral conjunctiva of the eye in much the same way as the Schirmer test. The
thread is yellow and changes to red when it is wet by tears. The test is performed
for 15 seconds, before the thread is removed and the red portion measured. A
measurement of more than 20 mm is considered normal, while a reading of less
than 10 mm is indicative of dry eye.71 While these tests are important in the
diagnosis of dry eye by clinicians, they do not pinpoint the cause or actual
pathology of the disease.

There is much research into the mechanism of dry eye disease, which is hindered
by the multifactorial nature of the disease and also the small size and high
complexity of the tear film. Studies have shown the importance of tear film
composition in its stability. In vitro studies evaluating the effect of meibum lipids
on evaporation demonstrated that they had little effect on the rate of evaporation
at physiological temperatures.72 This is likely due to the importance of interactions
between the meibum lipids and the components of the aqueous phase, such as
proteins and mucins. In vitro analysis of tear film surface pressure resulted in fully
saturated wax esters and cholesterol esters producing an unstable tear film, while
11

highly unsaturated molecules led to formation of a surfactant layer and a stable
tear film.73 It is studies such as these that highlight the importance of identifying
the molecular components of the tear film in order to understand their
interactions in both stable and unstable tear films.

1. 3 Lipids and their role in dry eye and contact lens wear
The term lipid refers to a diverse range of molecules traditionally characterised by
their solubility in organic solvents. Lipids are a vital component of cell membranes,
but are also important in other roles such as signal transduction and energy
storage.74 In addition, lipid dysfunction has been linked with a number of diseases,
such as cardiovascular disease and Alzheimer’s disease.75-76

Lipids can be broadly defined as simple or complex lipids, described by Fahey et al.
as:
“simple lipids being those yielding at most two types of products on hydrolysis
(e.g., fatty acids, sterols, and acylglycerols) and complex lipids (e.g.,
glycerophospholipids and glycosphingolipids) yielding three or more products
on hydrolysis.”77

Another method for classification is to divide lipids into non-polar and polar
groups. Non-polar lipids are completely hydrophobic molecules and include such
classes as wax esters and sterols. Polar lipids contain both a hydrophobic and
hydrophilic region, making the molecule amphiphilic. These molecules include the
12

sphingolipid and glycerophospholipid classes. This classification is useful when
discussing tear film lipids as it is thought that they form a layered structure, with
the amphiphilic polar lipids interacting with the aqueous phase and allowing the
spread of the hydrophobic non-polar lipids across the surface of the eye.52

The lipid component of the tear film accounts for only a small proportion of the
total tear film volume, but is believed to be vital in maintaining a stable tear film. 78
The assessment of the composition of tear film lipids is not complete and in recent
years has proved controversial. This is a consequence of the sample complexity
and the limited sample volume, with meibum or animal tears analysed in many
cases.

1.3.1 Non-polar lipids
Cholesterol is the most abundant sterol found in animal tissues and is vital in the
maintenance of membrane fluidity.79 It has a bulky tetracyclic structure, with a
hydroxyl group that allows hydrogen bonding with the aqueous phase and polar
phospholipid head groups (Figure 1.4A).79 These interactions increase the
orientational order of phospholipids within membranes and limit the rate of
motion of their fatty acyl chains.79

Previous studies have suggested that

cholesterol makes up 15% of tear lipids80 and has been detected at between 1 and
30% total meibum lipid.36, 81-84 The upper percentage observed in meibum analysis
was obtained using gas chromatography and it has been suggested that the
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degradation of cholesterol esters (see below) during the heating process may have
resulted in significantly more cholesterol being detected.84

Figure 1.4: The general structure of A) cholesterol, B) cholesterol ester, C)
triacylglycerol, D) diacylglycerol, and E) wax ester, where R', R'' and R''' are alkyl
chains.
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Cholesterol esters (CE) contain a fatty acyl chain esterified to the hydroxyl group,
which makes the molecule much less polar (Figure 1.4B). They have been
implicated in the storage and transport of cholesterol.85 Cholesterol esters are the
second most abundant lipid in meibum, making up 13-39% of total meibum.36, 44, 81,
86

Baron and Blough identified CE molecules with fatty acids ranging from 14:0

(i.e., containing 14 carbons and 0 double bonds) to 27:0, with the most abundant
being CE 25:0.82 Work by Nicolaides et al. confirmed this and showed that 77% of
CE was saturated.36 A recent study by Chen et al. using mass spectrometry
reported similar results, with CE 24:0, CE 25:0 and CE 26:0 being the most
abundant CEs observed, while in contrast Butovich et al. reported that the
unsaturated molecules CE 26:1 and CE 28:1, along with CE 25:0 were the most
abundant.87

Wax esters (WE) are the most abundant lipid in both tears and meibum,
accounting for 28-51% of total meibum lipids.36, 81, 86 Wax esters are made up of
fatty acyl chains esterified to fatty alcohols (Figure 1.4E).88 Butovich et al. analysed
individual molecules within the WE class, with the most abundant molecules made
up from unsaturated fatty acids with 18 carbons (18:1 > 18:2 > 18:3 > 18:4)
esterified to predominately saturated fatty alcohols ranging from 18:0 to 28:0 in
length.89

Minor non-polar lipids found in meibum include diesters, a diverse group of
molecules containing two ester bonds, which have been observed in meibum at 218% total meibum.36,

81, 83

Diacylglycerols (DAG) and triacylglycerols (TAG) are
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molecules with a glycerol backbone and either two (DAG) or three (TAG) fatty acyl
chains attached (Figure 1.4C and Figure 1.4D).88 DAGs make up only a small
percentage of meibum, detected between trace-3%,90-91 while TAGs were detected
at trace-10%.36, 81-83, 91

1.3.2 Polar lipids - phospholipids
Phospholipids are the most abundant class of membrane lipid. They are
characterised by the presence of a phosphate group esterified to a hydroxyl group
on the lipid backbone. They may contain a 3-carbon glycerol backbone, termed
glycerophospholipid (GP), or a sphingosine backbone, as is the case with
sphingomyelin (SM). The general structure of these lipids is shown in Figure 1.5.

A

B

Figure 1.5: The general structure of A) glycerophospholipid, and B) sphingomyelin.
The glycerol and sphingosine backbones are in black, while the hydrophilic region
is highlighed in red and the hydrophobic fatty acyl chains are blue, where R1 and R2
are alkyl chains.
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Within each of these phospholipid classes, there are a multitude of individual
molecules that differ in a number of areas. Generally in an SM molecule, there is a
trans double bond on the sphingosine backbone, but this bond may be saturated in
the case of dihydrosphingomyelin (DHSM). Glycerophospholipids are also further
diversified by a number of different head groups, the most common of which are
shown in Figure 1.6.

Figure 1.6: The structure of common head groups of glycerophospholipids.

17

The fatty acyl chains of both GPs and sphingolipids, shown in blue in Figure 1.5, are
highly variable. These long-chain carboxylic acids may differ in length, typically
ranging from 16 to 22 carbons in vertebrate phospholipids. They may be saturated
or contain up to six double bonds. Furthermore the position of the double bond can
differ. Fatty acyl chains are typically represented by the number of carbons
followed by the number of double bonds. For example, in Figure 1.7 the fatty acid
is made up of 16 carbons and one double bond between the 9th and 10th carbons
from the methyl end. This would be written 16:1 n-9.92 In some phospholipids the
substituent at the sn-1 position is bonded via a 1-O-alkyl-ether or 1-O-alk-1-enylether linked linkage.93

Figure 1.7: An example of an unsaturated fatty acid, with 16 carbons and one
double bond nine carbons from the methyl end.

Glycerophospholipids are named firstly by their head group and then by their fatty
acyl chains. The structure in Figure 1.8, for example, has a choline head group, a
saturated fatty acyl chain containing 16 carbons on the sn-1 position and a second
fatty acyl chain containing 18 carbons and one double bond at the sn-2 position
and would be referred to as PC (16:0/18:1).94 Where the total composition of the
molecule is known but not the identity of the individual fatty acyl chains, these
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may be combined to give the sum composition, with the molecule in Figure 1.8
written as PC (34:1).94-95

Figure 1.8: Structure of a phosphatidylcholine (PC) molecule with a 16:0 (16
carbons, zero double bonds) fatty acyl chain at the sn-1 position and an 18:1 (18
carbons, one double bond) fatty acyl chain at the sn-2 position. Nomenclature for
this molecule is PC (16:0/18:1 n-9).

Phospholipids are critical in membrane formation owing to their amphiphilic
nature, where the polar region interacts with an aqueous phase, while the nonpolar tails interact with each other, allowing them to form bilayers at the junction
of two phases.96 They can also be surface active, lowering the surface tension of a
liquid when they are spread across a liquid-air surface, with the hydrophilic
portion interacting with the aqueous phase and the hydrophobic portion oriented
towards the air.97

Determining the profile of the polar lipids of the tear film has been more
controversial than that of non-polar lipids. Polar lipids are believed to act as a
surfactant, allowing the spread of the more abundant non-polar lipids across the
aqueous surface of the tear film.44 Phospholipids were reported in most early
studies as being present in both tears80,

98

and meibum.36,

44, 99-100

It was

determined that phospholipids made up 4 - 15% total human meibum,36 and 15%
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of

total

human

tear

lipids.80

Phosphatidylcholine

(PC),

SM,

and

phosphatidylethanolamine (PE) have been reported to make up almost 80% of the
total phospholipid content in rabbit meibum,100 with ceramides and cerebrosides
also detected in human meibum.51,

101

A study by Greiner et al. using high-

performance liquid chromatography (HPLC) with UV detection determined that PC
was the most abundant phospholipid, composing 38% of total phospholipid, with
PE making up 16%, SM 7% and the remaining 39% being unknown. Sphingolipids
(excluding SM) made up 30% of total polar lipids and was primarily composed of
cerebrosides (70% total sphingolipids) with the other 30% being made up of
ceramides.51

The presence of phospholipids in the tear film has recently been challenged by
Butovich and co-workers90, 102-103 who used mass spectrometry to characterise the
human meibum lipidome and reported an upper limit of 0.01% phospholipid in
meibum samples. Their critique of earlier work suggested that the methods
employed (such as thin-layer chromatography and HPLC), as well as possible
contamination of samples with plasticisers, may have resulted in erroneous
observation of phospholipids. Furthermore, recent studies have revealed that the
profile of lipids in meibum differs to that of tears. Borchman et al. used both
infrared spectroscopy and fluorescence spectroscopy to compare the molecular
structure of meibum and tear lipids, with tear lipids containing fewer double
bonds, as well as either fewer hydrocarbons or longer hydrocarbons than meibum
lipids.104-105 Of particular interest was the decrease in intensity of bands
corresponding to phosphate moieties in meibum compared to tears, suggesting
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that there is less phospholipid present in meibum. Butovich et al. used HPLC
coupled with atmospheric pressure chemical ionisation mass spectrometry (APCIMS) to analyse differences in non-polar lipids. Tears contained a higher abundance
of lower mass molecules, as well as molecules with higher polarity than observed
in meibum.39 Their study suggested that the composition of tear film lipids was
more complex than that of meibum.

1.3.3 Polar lipids - OAHFAs
A recent development in the understanding of tear film polar lipids has come from
the identification of a series of specialised wax esters called (O-acyl)-ω-hydroxy
fatty acids (OAHFAs) in meibum.89 These unique lipids contain a fatty acyl chain
esterified to a long chain ω-hydroxy fatty acid (a long chain fatty acid with a
hydroxyl group on the terminal carbon). These molecules, which are now
becoming the focus of much research into tear film stability, will be discussed in
detail in Chapter 4.

1.3.4 Lipids and dry eye
Several studies indicate that the tear film lipid layer in patients with dry eye differs
to that of healthy patients.101,

106-109

Laser interferometry has been used to

illustrate visual changes in the tear film.108 Figure 1.9 shows an example of this
with the healthy eye (left) with a complete covering of lipid (i.e., oily surface) while
the spread of lipid is no longer uniform across the eye of the dry eye patient
(right), with no lipid in the lower margin and an accumulation of lipid in the left
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corner (as viewed) that had not been spread. Changes in meibum lipid composition
may affect the melting point, which in turn affects lipid spreading. 9 Other studies
have shown that the lipid layer in healthy eyes was significantly thicker than those
suffering from dry eye,109 and that tear evaporation increased by four-fold when
the lipid layer was non-confluent or absent.78

Figure 1.9: Laser interferometry of a normal eye (left) and a dry eye patient (right),
indicating differences in the spread of the lipid layer.108

Analysis of tear film lipids has shown differences in both the composition and
concentration with the occurrence of dry eye disease. Nicolaides et al. used an
animal model to analyse meibomian gland dysfunction and suggested that
hydrolysis of sterol esters occurred, showing an eight-fold increase in the long
chain fatty acids normally associated with sterol esters, together with an increase
in free sterols.110 Joffre et al. compared the fatty acyl chains of meibum in patients
with aqueous-deficient dry eye, meibomian gland dysfunction and healthy eyes.111
They used transmethylation of the lipids followed by gas chromatography (GC) and
GC-MS and revealed that, while aqueous-deficient dry eye patients had a similar
fatty acid composition to healthy patients, those with MGD had a significant
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reduction in saturated fatty acids, along with an increase in the levels of branchedchain fatty acids. Shrestha et al. used NMR to assess differences in lipids with
meibomian gland dysfunction and observed a 40% decrease in CEs when
compared to normal donors.112 Shine and McCulley used HPLC to analyse changes
in polar lipids with dry eye disease. They found that there was a significant
decrease in PE and SM levels in the meibum of patients with dry eye disease
compared to those from normal patients.101 They noted that the surfactant
properties of these two classes of phospholipids make them effective in the
maintenance of a stable tear film. While this work suggests correlations between
tear film lipid alteration and dry eye disease, more research is needed on the
specific molecular changes that occur.

1.3.5 Lipids and contact lens wear
As of 2004, approximately 125 million people worldwide wear contact lenses to
correct refractive error.113 They can be divided into two main types, soft lenses and
rigid gas permeable lenses. Rigid gas permeable lenses are less expensive and
more durable than soft contact lenses, however they are less comfortable. The
majority of wearers now use soft contact lenses, which are made from a soft plastic
that is more comfortable following insertion, but are susceptible to deposit
formation. Within this group there are a number of different materials that can be
used, one of the most recent developments being the silicone hydrogel contact
lens. These polymeric materials allow an increased flow of oxygen through the lens
to the ocular surface, which is important for corneal health. The hydrogel materials
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are also more wettable than rigid gas permeable lenses, i.e., the tear film is better
able to cover and maintain itself over the lens surface.114 Failure to achieve tear
film coverage of a lens has been linked to discomfort, decrease in lens performance
and contact-lens related dry eye, a common ophthalmic problem that results in
approximately 2.8 million users in the U.S. ceasing contact lens wear each year.113
Furthermore, contact lenses essentially divide the tear into a pre- and post-contact
lens film (Figure 1.10). This results in the spreading of the lipid layer over a much
thinner aqueous phase and also changes the surface which the eyelids must pass to
re-establish the tear film during a blink.115

Figure 1.10: Ultra-high resolution optical coherence tomography image showing
the formation of a pre- and post-lens tear film after contact lens insertion.116

Tear film components deposit rapidly onto the surface of a contact lens following
insertion.117 These deposits can lead to spoliation of the contact lens, a problem
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that may decrease lens performance and result in discomfort and infection.118-119
Research into the deposition of proteins onto contact lenses has been extensive.1,
120-126

Green-Church and Nichols analysed the deposition of proteins onto contact

lenses and found a total concentration of 7.32-9.76 µg/lens, however the
concentration and type of protein deposited varied with contact lens material
type.1 While the profile and quantification of proteins has been well documented,
there is only limited information on the deposition of lipids.

Electrostatic binding of lipids to contact lenses may be a contributing factor in
thinning lipid layers in the tear film and increased evaporation of the aqueous
phase.62 In vitro studies have shown that hydrogel lenses constructed from poly(2hydroxyethyl methacrylate) (pHEMA), a mixture of poly(methyl methacrylate)
(PMMA) and poly(vinyl alcohol) (PVA), or a combination of pHEMA with poly(vinyl
pyrrolidone) (PVP) and poly(methacrylic acid) (PMAA) can all adsorb lipids from
solution, and that lenses made from PMMA-PVA tended to adsorb slightly more
lipid.127 Lord et al. demonstrated that adsorption of cholesterol to pHEMA lenses
may collapse the hydrogel and expel water, whereas binding to PMMA lenses was
simply an adsorption process.128 In vitro experiments by Carney et al. involved
soaking a number of contact lens types in solutions of fluorescently tagged PE or
cholesterol to quantify their adsorption over time.129 They determined that the
concentration of lipid adsorbed was affected by contact lens material and that
cholesterol adsorption was significantly higher than PE for all lens types (3.0-24.1
µg/lens and 0.4–5.1 µg/lens, respectively). A later study by Pucker et al. showed
that PE and cholesterol oleate (a cholesterol ester) deposition was also affected by
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contact lens material, with deposition occurring rapidly (i.e. after one day). 130
Iwata et al. confirmed the ability of the silicone hydrogels to bind cholesterol in
relatively high levels and also demonstrated that these lens types could also bind
squalene, cholesterol esters and wax esters.131 Overall, these lipids bound to the
silicone hydrogel at levels between 0.4 to 7.6 µg/lens.

Initial in vivo studies demonstrated that lipid is present in contact lens deposits,
with the principal lipid type being CEs.132 White spots, a form of deposit found on
non-regularly replaced hydrogel lenses, have been shown to be predominantly
lipid.133-134 These deposits have a distinct structural stratification with a lipid layer
providing the interface between the contact lens surface and the deposit
superstructure. This initial interfacial layer is made from cholesterol, cholesterol
esters and unsaturated lipids.133-134 Jelly bump deposits, another form of deposit
on lenses, are composed of long and intermediate sized CEs, TAGs, and WEs.132

The influence of contact lens material on total lipid deposition has been analysed in
vivo using surface fluorescence analysis, with vifilcon A contact lenses depositing a
higher abundance of lipid than etafilcon A and netrafilcon A contact lenses.135 Zhao
et al. found that total protein and cholesterol concentrations were affected by lens
polymer and lens care solution used.136 While these studies have given some
insight into the deposition of total lipids, little is known about the profile of these
lipids or their comparison to the tear film lipid profile.
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1. 4 Thesis outline
This thesis hypothesises that (i) phospholipids are present in human tears, (ii)
these polar lipids originate from the meibomian glands, and (iii) they deposit onto
contact lenses. Therefore, the aim of this thesis is to examine in detail the
phospholipid component of human basal tears, meibum and contact lens deposits
using electrospray ionisation tandem mass spectrometry.

Chapter 2 details the method development required to enable investigation of
phospholipids in tears, meibum and contact lens deposits. This includes
optimisation of biphasic extractions to overcome the small sample size of
individual basal tear samples and the complexity of extracting from the polymeric
contact lens materials.

Chapter 3 seeks to clarify the conflicting reports in the literature on the presence
of phospholipids in human tears. It provides, for the first time, a molecular profile
of phosphocholine-containing lipids in tears. Furthermore, it explores the in vivo
deposition of tear lipids onto contact lenses, highlighting the importance of contact
lens material on the deposition of both representative polar and non-polar tear
lipid components.

In chapter 4, the question of whether tear phospholipids are derived from meibum
is addressed. The presence of phospholipids in human meibum is confirmed and a
more complete phospholipidome of tears and meibum is identified and compared.
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Chapter 5 investigates the effect of contact lens wear on tear phospholipids over
time. Phospholipid concentrations are analysed and compared to a number of
subjective patient parameters.

In chapter 6 a suite of mass spectrometric techniques are utilised to rigorously
investigate the structure of novel meibum lipids, (O-acyl)- -hydroxy fatty acids.
For the first time, their presence is reported in human tears and contact lens
deposits.

The final chapter (Chapter 7) summarises the work completed in this thesis and
discusses the implications these findings have for future studies.
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2 METHOD

DEVELOPMENT

FOR

THE

ANALYSIS OF LIPIDS DIRECTLY FROM
TEARS, MEIBUM AND CONTACT LENSES

2. 1 Introduction
Human tears are a complex mixture of molecules that play an important role in
ocular health and vision.9 While lipids only make up a small percentage of the tear
film, their presence may be vital in tear film stability.78 Analysis of tear lipids is
hindered by the small volumes of tears that can be collected from patients. It is
important that tear production is not stimulated prior to collection. Although
stimulation increases the volume of tears that can then be collected, it significantly
affects the protein profile, decreasing the amount of some proteins, while
increasing the concentration of serum proteins.137 Given that the tear film lipid
layer makes up such a small percent of the total tear film, it is likely that
stimulation would dilute tear lipids to undetectable levels.

Collection of basal tears has previously been obtained by the use of Schirmer
strips. This is a diagnostic technique that involves placing filter paper in the lower
conjuctival sac for 5 minutes. Tears can then be extracted directly from the filter
paper. This technique often yields a tear sample in excess of 10 µL,102 however
mucins and epithelial cells from the epithelial surface may also adhere to the
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surface.138 Collection of tears by microcapillary action is less invasive and limits
the contamination by epithelial cells, but the sample yield is small, often with 5 µL
or less collected. Previous studies have overcome this by pooling individual
samples.39,

139-142

This has the advantage of enabling larger tear samples to be

collected for analysis, but does not allow variations between individuals to be
measured, nor can temporal (or other) variation in the tear profile of an individual
be analysed.

One approach that has been employed to overcome the small concentration of
lipids in basal tears is to analyse meibum. Meibum is collected by squeezing the
eyelids, which forces the secretion from the orifice as a thin paste which can then
be collected using a spatula.51, 105, 143 This method yields ~ 1 mg of secretion, which
is almost exclusively composed of lipids. There is, however, recent evidence
suggesting meibum is not the sole source of tear film lipids.39,

54, 104-105

Furthermore, the secretion is forced and may not reflect the profile of the lipids
naturally delivered to the ocular surface.144

Animal models have been used to analyse the tear film and meibum.36,

98, 145-148

This enables disease states to be analysed under controlled conditions, reduces the
ethical concerns of in vivo experiments and also, in some cases, enables larger
samples to be obtained. The concern with animal models is that they may not be
representative of the human tear lipidome, with some studies demonstrating
significant differences between animal and human tears.103,

149

While animal

models and the use of meibum for tear film analysis have their benefits, ideally, a
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method developed to enable the identification and quantification of individual lipid
molecules within the small but complex tear sample would not only enable
verification of the tear lipidome, but also allow changes in lipids between groups to
be established.

The deposition of tear film components onto contact lenses occurs quickly
following insertion.117 As discussed in Section 1.3.5, this has implications for
contact lens comfort and also lens spoliation. Analysis of lipid deposition in vivo
has been limited, with most studies using in vitro models or analysing total lipid
only. The major limitations are the small concentration of lipids deposited onto the
lens, and the polymeric materials that make up the contact lens, which are also
easily extracted by organic solvents.

This chapter will discuss the development and optimisation of methods for the
extraction, identification and quantitation of lipids in tears, meibum and deposited
onto contact lenses.
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2. 2 Materials and methods
2.2.1 Materials
All phospholipid standards were synthesised by Avanti Polar Lipids (Alabaster, AL,
USA) and purchased from Auspep (Parkville, Vic, Australia). HPLC grade
chloroform and methanol, and analytical grade ammonium acetate were
purchased from Crown Scientific (Moorebank, NSW, Australia). Analytical grade
butylated hydroxytoluene (BHT) and D6-cholesterol were purchased from Sigma
Aldrich

(Castle

Hill,

NSW,

Australia).

Total

Recovery

vials

with

polytetrafluoroethylene (PTFE)/silicone septa were purchased from Waters
(Rydalmere, NSW, Australia). Borosilicate capillary tubing was purchased from
SDR Clinical Tech (Middle Cove, NSW, Australia).

2.2.2 Samples
All patients signed informed consent prior to enrolment into the study, which was
conducted in compliance with the tenets of the Declaration of Helsinki and was
approved by the Human Ethics Review Panel of the Brien Holden Vision Institute.
All samples were collected by the Brien Holden Vision Institute and sent to the
University of Wollongong for analysis.

32

2.2.2.1 Tears
Tears were collected using the method described in Sack et al.150 Briefly, basal
tears were collected using a glass capillary at the lower lid margin without
stimulating reflex tears. The samples were placed in pre-weighed glass vials and
the sample mass was recorded.

The samples were then stored at -80 oC.

Preliminary studies were performed using pooled tears which were obtained by
combining multiple samples to a total volume of between 50 – 500 µL.

2.2.2.2 Contact lenses
Patients wore either balafilcon A or senofilcon A contact lenses on a daily wear
basis for a period of up to 30 days, removing them each night and soaking them in
a known commercially available cleaning and disinfection solution. At the time of
collection, all contact lenses were removed with sterile gloves, rinsed with a
commercial saline solution and stored at -80 oC.

2.2.2.3 Meibum
Meibum samples were collected from volunteers by the methods described in
Butovich et al.,90, 143 with the exception that chloroform was not added to the vial
prior to collection. In brief, meibum was expressed using a cotton bud to squeeze
the eyelid and collected with a metal spatula. Care was taken to avoid scraping the
surface of the eyelid. Samples were then placed in pre-weighed glass vials, their
mass recorded, and stored at -80 oC until analysis.
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2. 3 Results and discussion
2.3.1 Lipid extraction from tears
Initial experiments on tears were performed on pooled basal tear samples from
multiple patients, resulting in a total of ca. 500 µL tears. The samples were
centrifuged (10 min, 11200g, 16 oC) to remove cellular debris before the
supernatant was collected by glass pipette and placed in a clean glass culture tube
(16 mm diameter; 125 mm long) with a screw cap. The method based on Folch151
and modified for mass spectrometry by Deeley et al.152-153 was used for lipid
extraction. All solvents were added using Eppendorf Combitips, unless otherwise
stated. The first step involved adding 2 mL of chloroform:methanol (2:1) mixture,
which contained 0.01 % of the antioxidant butylated hydroxytoluene (BHT). The
sample was shaken by hand for 15 min. Aqueous ammonium acetate (500 µL; 0.15
M) was added and the sample was vortexed before being centrifuged for 5 min
(2000g at 16 oC). The organic (bottom) phase was removed using a glass pipette
and placed in a clean culture tube. To the remaining aqueous (top) phase, 2 mL of
chloroform:methanol (2:1, 0.01 % BHT) was added and the above process of
vortexing and centrifugation was repeated. The organic phase was again removed
by glass pipette and the organic extracts combined. To the combined organic
phase, 500 µL of aqueous ammonium acetate (0.15 M) was added, the sample
vortexed and centrifuged. The aqueous phase was carefully removed and the
remaining organic sample was dried down under nitrogen at 37 oC, before being
reconstituted in 500 µL chloroform:methanol (1:2; 0.01% BHT). Prior to infusion,
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aqueous ammonium acetate (to final concentration of 50 mM) was added to the
sample to enhance formation of protonated ions during positive ion electrospray
ionisation.153-155

Samples were analysed by electrospray ionisation mass spectrometry (ESI-MS), a
technique that has become a vital tool in lipidomic research. This approach
facilitates the volatilisation, ionisation and analysis as lipid ions in either positive
or negative ion mode. The structure of the molecule and the polarity of the ESI
determines if the ionised lipids are protonated [M + H]+ or deprotonated [M – H]-.
Molecules are identified by their mass-to-charge (m/z), with the confidence in
identification dependant on the mass accuracy of the instrument and the
complexity of the sample. Mass accuracy refers to the difference between the
experimental and theoretical masses of a molecule and is usually measured in
parts-per-million (ppm).156 Instruments with high mass accuracy enable the
elemental composition of the molecule to be determined with a high degree of
confidence. If the mass accuracy of the instrument is not sufficient (as with the
instrument used here), complementary techniques, such as tandem mass
spectrometry (see below) may be employed to confirm molecular identification.156

Samples were infused into the instrument at a rate of 10 µL/min. Nitrogen was
used as the drying gas at a flow rate of 320 L/h. The capillary voltage was set to 3
kV, the source temperature to 80 oC and the desolvation temperature to 120 oC. A
mass-to-charge (m/z) range of 640-850 was used for initial experiments.
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Analysis of the extract by positive ion ESI-MS revealed a complicated mass
spectrum (Figure 2.1A) where phospholipids could not be easily detected. In
negative ion mode, the spectrum revealed a number of ions that appeared to be
part of a homologous series of lipids but the masses did not correspond to any
common phospholipids (Figure 2.1B). These ions will be discussed in detail in
Chapter 6.
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Figure 2.1: ESI-MS of tear lipid extract in A) positive ion mode, and B) negative ion
mode.

To simplify the complicated spectra observed in positive ion mode (cf. Figure
2.1A), a triple quadrupole (QqQ) mass spectrometer was utilised to enable tandem
mass spectrometry (MS/MS) experiments to be performed. In a traditional MS/MS
experiment in a QqQ, the ion of interest is isolated in Q1, followed by collisioninduced dissociation (CID) in q2 (collision cell). This involves fragmentation of the
ion by colliding it with an inert gas (in this case argon), with mass analysis of the
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resulting ionic fragments in Q3 (Figure 2.2 B). These fragments, known as product
ions, reveal specific structural features of the precursor and are used to aid
structure elucidation. Collision-induced dissociation of major phospholipid classes
have been extensively studied in positive and negative ion mode.93 These spectra
enable identification of the head group as well as the fatty acyl chains of most
phospholipids. This specific fragmentation can be exploited on the QqQ instrument
to allow targeted analysis of complex samples. Targeted scans, known as precursor
ion scans and neutral loss scans, have been used to great effect in lipid analysis. 153,
157-158

They were utilised here to allow molecules containing a common structural

motif to be analysed to the exclusion of other, sometimes more abundant, ions
(Figure 2.3).

In a precursor ion scan, Q1 scans all ions over a selected m/z range. These ions are
then fragmented by CID in q2 while Q3 is set to transmit only a single m/z. The
resulting spectra show only those precursor ions that yield the product ion of
interest (Figure 2.2C). An example of this is the precursor ion scan in positive ion
mode for the m/z 184 product ion, which is used to detect and identify lipids
containing the phosphocholine head group (Figure 2.3). A neutral loss scan works
in a similar manner, however in this case Q1 and Q3 are scanning a selected mass
range simultaneously, with Q3 scanning for a mass deficit corresponding to the
loss of a characteristic neutral fragment (Figure 2.2D). A 185 Da neutral loss scan
in positive ion mode, for example, enables elucidation of phosphatidylserine (PS)
molecules in a sample (Figure 2.3).
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Figure 2.2: A schematic diagram of triple quadrupole scanning capabilities.
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Figure 2.3: Targeted ion scans utilised for the analysis of lipid species in tear,
meibum and contact lens lipid extracts.159

Analysis of extracts from pooled tear samples using a precursor ion scan for the
phosphocholine head group (m/z 184) in positive ion mode gave a spectrum
where a number of PC and SM molecules could easily be observed (Figure 2.4).
These two species could be easily distinguished due to the extra nitrogen on the
sphingosine backbone giving SM ions an odd m/z while PC ions have an even m/z.
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Figure 2.4: Precursor ion scan for the phosphocholine head group (m/z 184) from
a pooled tear lipid extract.

2.3.2 Lipid recovery from small quantities of tears
Preliminary experiments using tears were performed with pooled tear samples.
While these samples are useful in the analysis of the overall lipidome, they may not
accurately reflect changes between groups. In order to accurately determine the
composition of the tear film, it is important that tear samples are collected from
patients without the stimulation of reflex tears. The collection of basal tears from
individuals resulted in an average collection ≤ 5 μL of tear. Analysis of such small
volumes required significant changes to the extraction procedure.

Initial experiments were performed using phospholipid standards. Standards (5
μL; PC, 0.8 µM; SM, 0.8 µM in methanol) were placed in 1.6 mL glass vials and the
above extraction procedure was used with the exception that the quantities of
solvents were reduced 10-fold for all steps and solvents were added using
disposable polypropylene pipette tips. Extracts and standards were analysed using
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the Waters QuattroMicro™ QqQ mass spectrometer but with a nano-electrospray
ionisation (nanoESI) source. In nanoESI, the ESI spray needle is replaced with a
metal coated capillary which has a tip of approximately 1-10 μm internal diameter.
A small amount of sample is loaded into the capillary and analysed at a flow rate of
approximately 20 nL/min.160 The reduction in flow rate and small orifice diameter
reduces the size of the droplets formed from the capillary which in turn increases
the ion transfer efficiency and decreases the contamination from salts.161 These
differences result in approximately two orders of magnitude greater sensitivity
using nanoESI compared to ESI.160 In these experiments, a 3 µL aliquot was placed
in a gold-coated borosilicate capillary and a capillary voltage of 1.5 kV was applied.
Desolvation gas was not used, but all other instrument parameters were the same
as those optimised for ESI. Results showed that little of the standard was
recovered. Furthermore, the reproducibility was poor, with spectra differing in
both overall ion count and in the relative abundance of the standard peaks.

Given the extremely low concentration and small sample volumes, it was
hypothesised that by simplifying the extraction method the recovery would be
greater. Standards (5 µL; PC, 0.8 µM; SM, 0.8 µM in methanol) were added to 1.6
mL glass vials. Initial centrifugation was not performed, thus removing the step of
transferring samples to a new vial and reducing the loss of sample.
Chloroform:methanol (2:1, 200 µL) was added and the samples were shaken for 10
min. Ammonium acetate (0.15 M, 50 µL) was added and the samples were
vortexed. The samples were then centrifuged (5 min, 2000g, 16 oC) before the
aqueous phase (top phase) was carefully removed. The samples were dried down
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under nitrogen and reconstituted in 10 µL chloroform:methanol (1:2, 0.01% BHT).
Analysis of samples indicated an improvement in the overall recovery of
standards, however the reproducibility was still poor. A possible reason for this is
the large surface area of the vial the lipids have been dried down in compared to
the very small volume the lipids were being reconstituted in.

To address this, further experiments included trialling different vials. Small
Eppendorf tubes (total volume 600 µL) and Waters Total Recovery HPLC vials
were used as both have tapered bases. Extractions were performed as in the
previous experiments, with the exception of reconstituting the extracted lipids in
100 µL of chloroform:methanol (1:2, 0.01% BHT) to ensure total reconstitution,
before carefully drying samples down under dry N2 to approximately 10 µL before
analysis. The resulting spectra (Figure 2.5) for triplicates of standards extracted
from plastic and from glass was analysed for reproducibility and compared back to
a spectrum of the original stock solution of standards. The PC and SM standards
were reproducibly extracted from the glass vials using the revised method. The
ratio of SM to PC was calculated using the ion count of each peak and was found to
be equal for both classes, which is similar to that of the stock solution. Extraction
from the Eppendorf tube showed a change in the ratio of SM to PC ions with SM
now 2.5 times larger than PC. A decrease in signal-to-noise as well as a decrease in
the total ion count (number on the top right side of each spectrum) was also
observed.
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Figure 2.5: Test of different vials used for extraction of lipids. A) A spectrum of the standards prior to deposition in the vial
and extraction. Triplicate spectra are of standard lipid extracts from B) plastic Eppendorf tubes; and C) extracts from Waters
Total Recovery HPLC glass vials. m/z 649 is DHSM standard, m/z 818 is PC standard. All spectra are precursor ion scans for
the phosphocholine head group (m/z 184) obtained in positive ion mode.
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An individual tear sample (3.4 µL) was first spiked with 5 µL of internal standards
(PC (19:0/19:0), 0.8 μM; SM (d18:0/12:0), 0.8 μM; PS (17:0/17:0), 0.5 μM; PE
(17:0/17:0), 0.5 μM; PG (17:0/17:0), 1 μM; and PA (17:0/17:0) 0.5 μM) in
methanol) before lipid extraction was performed in a Waters Total Recovery HPLC
vial as described above. A precursor ion scan for the phosphocholine head group
(m/z 184) resulted in a spectrum similar to that previously observed from the
pooled tear lipid extracts (Figure 2.6) and with both the DHSM and PC internal
standards observed at approximately 50 % of the base peak.
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Figure 2.6: Positive precursor ion scan for the phosphocholine head group (m/z
184) from a lipid extract of an individual tear sample showing a similar profile to
that observed from pooled tears.

2.3.3 Extraction from contact lenses
The extraction of lipids deposited onto worn contact lenses presented two major
challenges. Firstly, the concentration of lipids deposited is significantly smaller
than found in tissue, with the concentration of total lipid in human brain tissue
calculated at ca. 75 µg/mg wet tissue,162 while total lipid deposition onto contact
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lenses was calculated at between 9 - 48 µg per lens (lens mass ~40 mg).163
Secondly, contact lenses are made up of polymeric materials which are also
extracted by organic solvents.

Initial experiments were performed using unworn balafilcon A (Pure Vision,
Bausch & Lomb) and senofilcon A (Acuvue Oasys, Johnson & Johnson) contact
lenses spiked with phospholipid standards to allow for the optimization of lipid
extraction. As a control, contact lenses that had not been spiked were extracted
and analysed at the same time. The contact lenses fit in the bottom of a glass
culture tube (16 mm diameter; 125 mm long), which allowed the addition of 100
µL of a methanolic internal standard solution (PC (19:0/19:0), 0.4 µM; SM
(d18:0/12:0), 0.4 µM; PS (17:0/17:0), 0.25 µM; PE (17:0/17:0), 0.25 µM; PG
(17:0/17:0), 0.5 µM; and PA (17:0/17:0) 0.25 µM) to be added to the convex
surface using a disposable polypropylene pipette tip. The excess solvent was
evaporated under nitrogen. Chloroform:methanol (2 mL; 2:1 with 0.01% BHT) was
added to each culture tube before they were sealed and shaken by hand for 20
mins. During the shaking step, the contact lenses often broke up, with senofilcon A
lenses proving more fragile. The solution was removed from the test tube using a
glass pipette, with care taken to avoid further breaking up the contact lens. The
solution was placed in a clean test tube and aqueous ammonium acetate (500 µL;
0.15 M) was added. A biphasic extraction was performed as described for the
pooled tear samples (Section 2.3.1).
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Contact lens extracts were analysed by ESI-MS using the same instrumental
parameters as with initial pooled tear samples. A positive ion MS scan of both lens
types revealed ions of high abundance, with a representative spectrum from a
senofilcon A extract shown in Figure 2.7A. In this spectrum a repeating pattern of
ions can be observed that are separated by 74 Th, e.g., m/z 682, 756 and 830. This
pattern is generally indicative of a series of oligomers, likely from the contact lens.
The mass difference appears consistent with a monomer of polydimethylsiloxane,
which is a constituent of senofilcon A contact lenses. A precursor ion scan for the
phosphocholine head group (Figure 2.7B), however, clearly showed the spiked
DHSM (m/z 649) and PC (m/z 818) standards, while extracts from non-spiked
contact lenses showed only low intensity noise that was below the limit of
detection used in this thesis (spectrum not shown). Interestingly, there was a
difference in the ratio of DHSM and PC between the two lens types, with balafilcon
A lenses having an almost 1:1 ratio (consistent with the standards), as shown in
Figure 2.7C. This suggests that binding of the two phospholipid classes is different
between the different lens types.
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Figure 2.7: ESI-MS of unworn contact lens lipid extracts. A) Positive ion MS scan of
an extract from a spiked senofilcon A lens extract revealing a number of high
abundance ions. B) Positive precursor ion scan for the phosphocholine head group
(m/z 184) of a senofilcon A extract showing both internal standards. C) Positive
precursor ion scan for the phosphocholine head group from an unworn balafilcon
A contact lens extract showing both DHSM and PC internal standards. Numbers on
right indicate the intensity of the base (highest) peak.

While the use of targeted ion scans allowed the observation of phospholipid
standards in a contact lens extract, the high amount of non-lipid material
complicates the mass spectra and likely suppresses the ion signal of molecules of
interest. Given that contact lenses are made up of polymeric materials, which are
easily extracted by organic solvents such as chloroform, it was hypothesised that
reducing the amount of chloroform used in extraction may reduce the extraction of
contact lens materials, thus increasing the selectivity of the lipid extraction. To test
this, unworn contact lenses were spiked with internal standards and then the
extraction was performed as above except the chloroform:methanol ratio was
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changed from 2:1 to 1:1. Extracts were dried down as before and reconstituted in
chloroform:methanol (1:2, 0.05% BHT) for MS analysis.

The resulting full MS spectrum (Figure 2.8A) revealed that there was no reduction
in the extraction of the contact lens material compared to the sample extracted
with 2:1 chloroform:methanol (base peak intensity of 5.59 x 105 and 1.24 x 105
counts, respectively), in fact the spectrum appeared more complicated and with a
lower signal-to-noise ratio than that in Figure 2.7A. Analysis of the phosphocholine
standards by precursor ion scan (Figure 2.8B) revealed a significant reduction in
the amount of phospholipid extracted from the lens, with a base peak intensity of
only 313 counts (compared to 2.68 x 103 in Figure 2.7).
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Figure 2.8: Positive ion ESI-MS of unworn senofilcon A contact lens extracted with
1:1 chloroform:methanol. A) MS scan, B) Positive precursor ion scan for the
phosphocholine head group (m/z 184).
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Another concern with the extraction method was the breaking up of the contact
lenses on shaking and the difficulty in removing all of the solution containing the
desorbed lipids from the test tube. When the contact lenses break up the surface
area exposed to the solvent is increased and may amplify extraction of contact lens
components. To lessen the risk of breaking, contact lenses were placed in
individual 25 mL beakers. This made it easy to manoeuvre the lenses into the
correct position but made it more difficult to add the internal standards as they did
not hold their shape and the internal standard often leaked onto the beaker
surface. Doubling the concentration of the internal standards meant only 50 µL
was needed, which was more manageable and little, if any, standard was lost.

The use of the beakers meant that 3 mL of chloroform:methanol (2:1, 0.01 % BHT)
was required to ensure that the contact lenses were covered. The beakers were
covered with aluminium foil and placed on an orbital shaker (Bioline, London, UK)
at low speed for 15 minutes. After this time, the lenses had not broken up and the
solution containing the desorbed lipids was easily removed with little to no
damage of the contact lens. The extraction was then carried out as before. This
procedure allowed reproducible extraction of lipid standards from the unworn
contact lenses (representative spectrum shown in Figure 2.9A) and was then
tested on worn contact lenses. Lipids extracted from worn contact lenses using this
method and analysed by precursor ion scan for the phosphocholine head group
(Figure 2.9B) showed both SM and PC internal standards (m/z 649 and m/z 818,
respectively), along with a number of SM molecules ranging from SM 14:0 (m/z
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675) to SM 24:1 (m/z 813). A number of PC molecules were also observed,
particularly at m/z 758 (PC 34:2) and m/z 786 (PC 36:2).
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Figure 2.9: Positive precursor ion scan for the phosphocholine head group (m/z
184) from A) an unworn senofilcon A contact lens extract, and B) a worn contact
lens (senofilcon A) extract.

2.3.4 Extraction from meibum
Individual meibum samples (~ 0.1 mg) were extracted using the same method
optimised for individual tear samples (Section 2.3.2), with the exception that 2.5
µL of the phospholipid standard solution was added prior to extraction. Samples
were analysed using nanoESI-MS/MS using the same conditions as the individual
tear samples, with a number of phospholipids detected (Figure 2.10).
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Figure 2.10: Positive precursor ion scan for the phosphocholine head group (m/z
184) from a meibum lipid extract.

2.3.5 Identification/quantification
Identification of phospholipids was achieved by combining the use of precursor ion
and neutral loss scans for specific head groups, and the m/z obtained. In this way,
an identification of the head group and the total number of carbons and level of
unsaturation of the fatty acyl chains could be determined, e.g. the ion at m/z 758
was identified as PC 34:2 (34 carbons and two double bonds). These spectra could
not be used to determine the individual fatty acyl chains.

Lipids could be quantified from crude extracts by including standards of a known
mass and concentration prior to lipid extraction. The standards used were
synthetic with masses not normally found in nature. It was important that internal
standards were present for each of the lipid classes to be analysed, 164 to account
for differences in the ionisation efficiency of the various lipid classes. In the case of
phospholipids, the ionisation efficiency is related to head group structure. 164
Previous studies analysing equimolar amounts of phospholipids in negative ion
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mode showed that phosphatidylglycerol (PG) has the highest ionisation efficiency,
with phosphatidylinositol (PI), PE and phosphatidic acid (PA) having moderate
efficiencies, while PS and the Cl- adduct of PC have the lowest ionisation
efficiency.164 In positive ion mode, however, the intensity of PC was substantially
greater than the other classes. This response affects the relative ion abundance of
molecules in a complex sample, with ions that have a higher ionisation efficiency
appearing at a higher abundance to those with equimolar abundances but a lower
ionisation efficiency.

A second consideration when quantifying lipids from ion abundances is the
isotopic distribution of the lipids. Firstly, the relative abundance of the heavier
isotopologues [M+1], [M+2] etc. increase with increasing molecular size. The
contributions of these isotopologues must be combined to enable accurate
quantitation. Secondly, the abundance of the mono-isotopic ion from one lipid can
overlap with that of the [M+2] isotopologues of another, e.g., where two lipids
differ by one double bond (Figure 2.11). This contribution must be subtracted for
accurate quantitation of the lipid in question. Theoretical modelling of the isotopic
distribution enables both effects to be corrected.
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Figure 2.11: Theoretical isotope distribution of A) PC 34:2 (m/z 758); and B) PC
34:1 (m/z 76). C) Theoretical distribution when molecules are combined in
equimolar concentrations.

An Excel template was used to simulate isotopic distributions and applied the
necessary corrections to enable quantification of individual and total lipids within
a class (Figure 2.12). The 13C isotopic distribution for each molecule was calculated
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using MassLynx isotope modelling function and inputted as a ratio of the molecular
ion, which allowed calculation of the relative ion abundance of the three
isotopologues. Analysis began with the smallest ion, which allowed correction for
an isotopologue of a lower m/z ion contributing at the mono-isotopic peak of a
heavier ion. The abundance could then be summed for all isotopes, eliminating
discrimination based on size and isotopic ratio differences. The isotope sum for
each ion was normalised to the isotope sum of the internal standard which then
allowed quantification of each individual phospholipid present within the class.
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Figure 2.12: Representative of the spreadsheet used to calculate isotope correction and quantification of lipids within a class.
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2.3.6 Limit of detection/limit of quantification
A number of the phospholipids detected in tear, meibum and contact lens
extracts were of low relative abundance. It was important therefore to establish
a robust limit of detection. Armbruster et al.165 developed a method for
calculating the limit of detection (LOD) and limit of quantification (LOQ) of a GCMS instrument by running a series of blanks and calculating the mean and
standard deviation (s.d.) from these. Here, instead of running blanks, a region of
the spectrum where no ions were expected was used. For each scan type, the
noise for a 3 Th region was averaged and the mean and s.d. were calculated.
From these, the LOD was determined by multiplying the s.d. by 3 and adding
that to the mean. The LOQ was calculated at the mean plus the s.d. multiplied by
10. Only ions above these limits were included in further analysis.

The level of noise observed in the spectra differed between scan types and also
from day to day. Therefore, for each day, the LOD and LOQ were calculated for
each precursor and neutral loss scan used.
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2. 4 Conclusions
The experiments performed in this chapter revealed:

i.

Small quantities (ca. 5 µL) of tears could be reproducibly extracted using
a biphasic extraction with chloroform: methanol (2:1) and aqueous
ammonium acetate. Waters Total Recovery HPLC vials were the optimal
vial for the extraction to be performed in. Eppendorf tubes were also
trialled but the results showed losses in phospholipids and a decrease in
reproducibility.

ii.

Extraction of lipids from contact lenses was made more difficult by the
simultaneous extraction of contact lens material that dominated MS
spectra. Reducing the amount of chloroform in solvent (from 2:1 to 1:1
chloroform:methanol) did not significantly reduce the amount of contact
lens material extracted, but did reduce the extraction of phospholipids
from the contact lens. Whilst lipids could not be observed in MS scans,
the use of precursor ion scans allowed targeted analysis of phospholipids
within the complex extract, with 2:1 chloroform:methanol shown to
reproducibly extract lipids from the contact lens.

Resulting from the work described in this chapter, a set of optimised methods
were developed and are described in Section 2. 5. These methods were applied
for the extraction and analysis of tears, meibum and contact lens lipids in
Chapters 3, 4, 5 and 6.
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2. 5 Optimised procedures
2.5.1 Materials
All phospholipid standards were synthesised by Avanti Polar Lipids (Alabaster,
AL, USA) and purchased from Auspep (Parkville, Vic, Australia). HPLC grade
chloroform and methanol, and analytical grade ammonium acetate were
purchased from Crown Scientific (Moorebank, NSW, Australia). Analytical grade
butylated hydroxytoluene (BHT) was purchased from Sigma Aldrich (Castle Hill,
NSW, Australia). Total Recovery HPLC vials with polytetrafluoroethylene
(PTFE)/silicone septa were purchased from Waters (Rydalmere, NSW,
Australia). Borosilicate capillary tubing was purchased from SDR Clinical Tech
(Middle Cove, NSW, Australia). MilliQ™ water from Millipore (Billerica, MA) was
used.

2.5.2 Tear collection
Basal tears were collected by capillary action using a glass capillary at the lower
lid margin without stimulating reflex tears. Tears were placed in a pre-weighed
glass HPLC vial, their mass recorded, and stored at -80oC.

2.5.3 Contact lens collection
Patients wore contact lenses every day for 30 days, with lenses removed each
night and soaked in a commercially available cleaning and disinfection solution.
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At the time of collection, all contact lenses were removed with sterile gloves,
rinsed with a commercial saline solution, and stored at -80°C.

2.5.4 Meibum collection
Meibum was expressed using a cotton bud to squeeze the eyelid and collected
with a metal spatula, with care taken to avoid scraping the surface of the eyelid.
Collected meibum was placed in a pre-weighed glass HPLC vial, the mass
recorded, and stored at -80oC.

2.5.5 Lipid extraction from tear samples
Tear samples were spiked with 5 µL of a methanolic internal standard mix (PC
(19:0/19:0), 0.8 μM; SM (d18:0/12:0), 0.8 μM; PS (17:0/17:0), 0.5 μM; PE
(17:0/17:0), 0.5 μM; PG (17:0/17:0), 1 μM; and PA (17:0/17:0) 0.5 μM) before
200 µL of chloroform:methanol (2:1; 0.01% BHT) was added. Samples were
vortexed prior to being placed on an orbital shaker (Bioline, London, UK) at low
speed for 10 minutes. If samples had not arrived in Waters Total Recovery HPLC
vials, they were transferred to new vials at this time. Aqueous ammonium
acetate (50 µL; 0.15 M) was added and the samples were vortexed prior to
centrifugation for 5 min (2000g; 16 oC). The aqueous phase was removed using
a Pasteur pipette taking care not to disturb the organic phase. Samples were
dried down under nitrogen before being reconstituted in 100 µL of
chloroform:methanol (1:2; 0.01% BHT). Samples were stored at -80 oC until
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required. Prior to analysis, samples were gently dried down under nitrogen to
approximately 10 µL.

2.5.6 Lipid extraction from worn contact lenses
The contact lens was placed in a 25 mL glass beaker in a concave orientation.
Internal standard (50 µL; (PC (19:0/19:0), 0.8 μM; SM (d18:0/12:0), 0.8 μM; PS
(17:0/17:0), 0.5 μM; PE (17:0/17:0), 0.5 μM; PG (17:0/17:0), 1 μM; and PA
(17:0/17:0) 0.5 μM) in methanol) was added to the concave (post) surface of
the contact lens and dried down under nitrogen. Chloroform:methanol (3 mL;
2:1 v/v) containing 0.01% BHT was added to the beaker before it was covered
with aluminium foil and shaken on an orbital shaker (Bioline, London, UK) at
low speed for 15 minutes. The solution containing the desorbed lipids was
removed, with care taken not to break the contact lenses, and placed in a clean
glass culture tube. Aqueous ammonium acetate (500 µL; 0.15 M) was added to
the culture tube before it was vortexed and centrifuged for 5 minutes (2000g;
16 oC). The organic (bottom) phase was removed and placed in a second clean
glass culture tube. To the first culture tube, 2 mL of chloroform:methanol (2:1
v/v; 0.01% BHT) was added before vortexing and centrifugation was repeated
as previously. The organic phase was again removed and combined in the
second culture tube. To this a further 500 µL of aqueous ammonium acetate
(0.15 M) was added and vortexed, before centrifuging for a third time. The
aqueous (top) phase was removed, before the sample was dried down under
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nitrogen at 37oC. Samples were reconstituted in 500 µL chloroform:methanol
(1:2; 0.01% BHT) and stored at -80 OC until required.

2.5.7 Lipid extraction from meibum
Meibum was collected and placed in a pre-weighed Waters Total Recovery HPLC
vial. Samples were spiked with 2.5 µL of methanolic internal standard mix (PC
(19:0/19:0), 0.8 μM; SM (d18:0/12:0), 0.8 μM; PS (17:0/17:0), 0.5 μM; PE
(17:0/17:0), 0.5 μM; PG (17:0/17:0), 1 μM; and PA (17:0/17:0) 0.5 μM).
Chloroform:methanol (200 µL; 2:1 v/v; 0.01% BHT) was added to the vial
before it was vortexed and then shaken on an orbital shaker at low speed for 10
minutes. If samples had not arrived in Waters Total Recovery HPLC vials, they
were transferred to new vials at this time. Aqueous ammonium acetate (50 µL;
0.15 M) was added to the vial which was then vortexed before centrifugation for
5 min (2000 x g; 16oC). The aqueous phase was removed using a Pasteur
pipette, with care taken not to disturb the organic phase. The organic phase was
dried down under nitrogen and reconstituted in 100 µL of chloroform:methanol
(1:2; 0.01% BHT) and stored at -80OC until required. Prior to analysis, samples
were gently dried down under nitrogen to ~10 µL.

2.5.8 Mass spectrometry
Unless otherwise stated, all MS analysis was performed on a Waters
QuattroMicro™ QqQ mass spectrometer (Manchester, UK) with Masslynx 4.0
software. Prior to infusion, 1 M aqueous ammonium acetate was added to all
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samples to give a final concentration of 50 mM. For ESI analysis, samples were
infused at a flow rate of 10 µL/min. For nanoESI analysis, capillaries were
prepared from borosilicate tubing using a micropipette puller (Flaming/Brown;
Sutter Instrument Co., Novato, CA) and gold coated with a sputter coater
(K500X; Emitech, East Sussex, UK). Approximately 3 µL of sample was loaded
into the capillary for analysis. All contact lens lipid extracts were analysed by
ESI, while tear and meibum were analysed by nanoESI. Table 2.1 contains the
parameters used for MS and targeted ion scan (MS/MS) analysis in positive and
negative ion mode. Those underlined indicate the changes to parameters for
nanoESI, otherwise parameters were the same for both sources. The collision
energies for the targeted ion scans used in this project are shown in Table 2.2.
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Table 2.1: Instrument parameters used for ESI-MS and targeted ion scan
(MS/MS) analysis on the Waters QuattroMicro™ triple quadrupole mass
spectrometer. Values underlined represent those altered for nanoESI source.
Parameter
MS
MS/MS
Capillary (kV)

3.0/1.5

3.0/1.5

Cone (V)

50.0 pos/35.0 neg

50.0 pos/35.0 neg

Extractor (V)

2.00

2.00

RF lens (V)

0.0

0.0

Source temperature (oC)

80

80

Desolvation gas flow rate

320/0

320/0

Desolvation temperature (oC)

120/N/A

120/N/A

LM 1 resolution

15.0

15.0

HM 1 resolution

15.0

15.0

Ion energy 1

0.5

1.0

Entrance

50

-2

Collision energy

2

See Table 2.2

Exit

50

1

LM 2 resolution

15.0

15.0

HM 2 resolution

15.0

15.0

Ion energy 2

0.6

1

Multiplier (V)

650

650

Gas cell pirani pressure

< 1.0e-4

3.0e-3

(L/hr)

(mbar)
N/A, not applicable.
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Table 2.2: Targeted ion scans.
Scan type
Targeted ion

Collision energy (eV)

Features identified*

POSITIVE
Precursor

m/z 184.1

35

PC/SM

Neutral loss

185.0 Da

22

PS

Neutral loss

141.0 Da

25

PE

Precursor

m/z 369.4

25

CE

Precursor

m/z 253.4

50

16:1

Precursor

m/z 255.4

50

16:0

Precursor

m/z 269.4

50

17:0

Precursor

m/z 279.4

50

18:2

Precursor

m/z 281.4

50

18:1

Precursor

m/z 283.4

50

18:0

NEGATIVE

*PC, phosphatidylcholine; SM, sphingomyelin;
phoshatidylethanolamine; CE, cholesterol ester.

PS,

phosphatidylserine;

PE,

Spectra were typically obtained over a mass range of m/z 640-860 in positive
ion mode and m/z 640-900 in negative ion mode. For ESI, a scan rate of 200 Th
per second was used, and 300 scans were combined. The scan rate for nanoESI
was 2 sec, with 100 scans combined. All spectra (both ESI and nanoESI) were
then processed using background subtraction and smoothing with a SavitskyGolay algorithm.

2.5.9 Limit of detection and limit of quantification
Each day, the LOD and LOQ of the instrument were calculated for each
precursor and neutral loss scan. The average noise was calculated for each
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spectrum by averaging the total noise intensity in a 3 Th region where no
ionised lipids were expected. The mean and standard deviation (s.d.) were
calculated and the LOD and LOQ were determined by the following equations:

LOD = mean + 3 x s.d.
LOQ = mean + 10 x s.d.

The centroid function was applied to the spectra using peak areas to determine
the area under the curve. Any peaks with an intensity below the LOD were
excluded from further analysis. Those with an intensity above the LOD but
below the LOQ were included in identification but not in quantitative analysis.
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3 LIPIDS IN TEARS AND DEPOSITED ONTO
WORN CONTACT LENSES
Research described in this chapter has been published in:
Jennifer T. Saville, Zhenjun Zhao, Mark D.P. Willcox, Stephen J. Blanksby, Todd
W. Mitchell. (2010) Detection and Quantification of Tear Phospholipids and
Cholesterol in Contact Lens Deposits: The Effect of Contact Lens Material and
Lens Care Solution. Investigative Ophthalmology and Visual Science. 51: 28432851.

3. 1 Introduction
The tear film lipid layer is a vital component in the preservation of a stable tear
film and in the prevention of excess evaporation of the aqueous phase (see
Section 1.1). Much of the previous work on tear film lipids has involved analysis
of meibum or the use of animal models.82, 100 Given the recent controversy on
the presence or absence of phospholipids in meibum,39, 102 and questions over
the origin of tear lipids,

39, 54, 104-105

the need for a detailed analysis of human

tear samples is clear.

Tear film components deposit rapidly onto the surface of a contact lens
following insertion.117 These deposits can lead to spoliation of the contact lens, a
problem that may decrease lens performance and result in discomfort and
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infection.118-119 Research into the deposition of proteins onto contact lenses has
been extensive,1, 120-122 while the deposition of lipids has received less attention
(see Section 1.3.5). Silicone hydrogels are the most commonly used type of
contact lenses, with 67% of patients in the USA fitted with these contact lenses
in 2011.166 Silicone hydrogels allow an increase in oxygen permeability to the
cornea,167 but a more hydrophobic lens surface has also been linked with an
increase in lipid deposition.168 With a current global contact lens market of
approximately $6.8 billion and more than 125 million contact lens wearers
worldwide,166 ensuring contact lens performance and ocular health is very
important.

In this chapter, the phospholipid profile of human basal tears was determined
and compared to that obtained from worn silicone hydrogel contact lenses. The
effect of contact lens material and lens care solution on phospholipid and
cholesterol deposition was also examined.
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3. 2 Methods
3.2.1 Contact lens samples
Contact lens samples were collected as per Section 2.5.3. Patients (10 male and
13 female; mean age 36.5 years) wore either balafilcon A or senofilcon A contact
lenses on a daily wear basis for a 30 day period, removing them each night and
soaking them in known commercially available cleaning and disinfection
solutions (Table 3.1).
Table 3.1: Ingredients of the lens care solutions used in this study.
Solution Surfactant
Preservative
A
Tetronic 1304
Polyquad 0.001%, Aldox 0.0005%
B
Poloxamer 407, Poloxamine Alexidine 0.00045%
1107
C
Pluronic 17R4
Hydrogen peroxide 3%

3.2.2 Tear samples
Tears were collected from non-contact lens wearing patients using the method
described in Section 2.5.2.

3.2.3 Lipid extraction from contact lenses and tears
Tear and contact lens lipid extracts were prepared by the optimised methods
described in Section 2.5.5 and Section 2.5.6, respectively, with the exception
that 4 µg/lens of D6-cholesterol was added with the polar internal standards
prior to extraction.
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3.2.4 Mass spectrometry of polar lipids
All samples were analysed using a Waters QuattroMicro™ QqQ mass
spectrometer (Manchester, UK), as described in Section 2.5.8. Tear samples
were analysed by nanoESI-MS/MS, while contact lens extracts were analysed
using ESI-MS/MS.

3.2.5 Mass spectrometry of cholesterol
A Shimadzu™ QP5050 GC-MS was used to quantify cholesterol in all samples by
direct-insertion electron ionization mass spectrometry (DI/EI-MS) using the
method described by Deeley et al.153 In brief, approximately 10 μL of sample
was dried on the end of a sealed glass capillary tube, which was directly
inserted into the source of the mass spectrometer. A temperature program was
used to heat the tube from 40oC to 250oC at 80oC/min. Selected ion monitoring
(cholesterol: m/z 386, 368, 353; D6-cholesterol: m/z 392, 374, 359) was used
(Figure 3.1). The ion intensity ratios of the D6-cholesterol and cholesterol in
each sample were used in conjunction with a standard curve to calculate the
concentration of cholesterol in each sample. This method measures free
cholesterol only, as cholesterol esters have a separate distinct elution profile
under these conditions.
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Figure 3.1: Typical data obtained from direct insertion electron ionization mass
spectrometric analysis of cholesterol from a contact lens extract. A) Mass
spectrum showing the characteristic ions for cholesterol (m/z 353, 368 and
386) and D6-cholesterol (m/z 359, 374 and 392). B) The selected ion monitoring
chromatogram with the elution profile of cholesterol and D6-cholesterol ions.

3.2.6 Statistical analysis
Data were analysed by a one-way ANOVA using contact lens material or lens
care solution as a fixed factor, with a Student’s t-test for comparison of means.
All values are expressed as means ± S.E. and p values of < 0.05 were considered
statistically significant. All data were analysed using JMP 5.1 (SAS Institutes, NC,
USA).
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3. 3 Results and discussion
3.3.1 Phospholipids in tears and contact lens deposits
In this Chapter the profile of phospholipids in tears and deposited onto contact
lenses and the effect of contact lens material and lens care solutions on the
concentration of total and individual quantifiable phospholipids and cholesterol
was analysed. While previous studies have established the profile of proteins in
tears,80,

137, 169

little work has been performed in the identification of

phospholipids in tears and the profile of non-polar lipids is still controversial.
Analysis of choline-containing phospholipids in human basal tears revealed a
number of PC and SM molecules, including the elucidation of those differing by
only one double bond in the fatty acyl chains. Using shotgun lipidomics, a
technique that is now well established in the analysis of lipids in tissues, 96, 153,
170-172

23 molecular lipids were detected and identified in tears in SM and PC

classes. The combination of low lipid concentrations and sample volumes did
not allow for additional experiments to differentiate between SM and DHSM or
determine individual fatty acid composition. PC and SM have been previously
reported in tears105 and in vitro studies by Peters and Millar173 have suggested
that PC increases the stability of the tear film by lowering surface tension. Other
studies have associated the hydroxyl group present in SM with an increase in
hydrogen bonding and therefore stable structure formation in the tear film.101

The total concentration of SM in tears was calculated as 5 ± 1 pmol/μL, while
the total concentration of PC was 6 ± 1 pmol/μL, with the two most abundant
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phospholipids observed in this analysis being SM 16:0 (m/z 703) and PC 34:2
(m/z 758) (Figure 3.2A). The degree of unsaturation of PC was greater than SM,
which was dominated by SM 16:0. Previous work using thin-layer
chromatography and high-pressure liquid chromatography with ultraviolet
detection has suggested that the concentration of PC in meibum is
approximately 5 times greater than SM,51 however the results here suggest that
the concentration of PC and SM in tears is approximately equal. This
discrepancy may be further evidence of the differences between meibomian
gland and tear film lipids as previously suggested.39, 54, 104-105 Other classes of
phospholipids (i.e., PE, PS) have been previously reported in meibomian gland
secretions51, 99-100 but were below the LOD in this analysis of tears.

Comparison of phosphocholine lipid profiles revealed that contact lens lipid
extracts exhibit a similar profile to that seen in tear extracts (Figure 3.2A and B)
with differences in SM attributed to contact lens material specificity (See
Section 3.3.2 below). Comparison of individual molecules as a percent of total
SM or PC showed differences in the SM profile, with contact lens lipid extracts
containing a significantly larger percentage of SM 16:0, but no significant
differences in the PC profile (Figure 3.2C and D).
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Figure 3.2: Comparison of tear and contact lens phosphocholine profiles.
Representative spectra of precursor ions scans for the phosphocholine head
group (m/z 184) from, A) a tear lipid extract, and B) an extract from worn
senofilcon A contact lenses washed with a Polyquad, MAPD and tectronic 1304
wash solution. C) Concentration of individual sphingomyelin (SM) and
dihydrosphingomyelin (DHSM) molecules in tear and senofilcon A contact lens
extracts, shown as a percent of total sphingomyelin. D) Concentration of
individual phosphatidylcholine (PC) molecules in tear and senofilcon A contact
lens extracts, shown as a percent of total phosphatidylcholine. Data are
presented as mean + S.E. •p < 0.01; * p < 0.05.
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3.3.2 Effect of lens material and lens care solution
While the overall profile was similar for both tear and contact lens lipid extracts,
there were differences observed in the phospholipids detected that were
dependant on contact lens material and lens care solution. A number of
phospholipids were detected in contact lens extracts, but not in tear extracts.
This could arise from accumulation on the contact lens during wear allowing the
concentration to reach levels above the LOD. Table 3.2 lists the individual
phospholipids that were observed in samples at ion counts above the calculated
LOD. The greatest number of individual phospholipids were detected from
senofilcon A lenses disinfected and cleaned with solution A, whilst the fewest
number were detected in both tear extracts and balafilcon A lenses disinfected
and cleaned with solution C.
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Table 3.2: Phospholipids detected in tear and worn contact lens lipid extracts.
Only lipids with ion counts above the calculated Limit of Detection (LOD) are
included.
Lipid*
SM 14:0
SM 15:0
SM 16:1
SM 16:0
DHSM 16:0

m/z
[M+H]+
675
689

Tears



701

Senofilcon A
Solution A



Balafilcon A
Solution A




Balafilcon A
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Balafilcon A
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PC 26:0

785
787
811
813
815
650
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PC 30:0
PC 32:1
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732
734














SM 18:1
SM 18:0
SM 20:1
SM 20:0
SM 22:2
SM 22:1
SM 22:0
SM 24:2
SM 24:1
*DHSM 24:1

PC 32:0
PC 33:1/
PC O-34:1†
PC 34:3
PC 34:2
PC 34:1
PC 36:4
PC 36:3
PC 36:2
PC 36:1
PC 38:6
PC 38:5
PC 38:4






746



756



758
760
782
784

























786
788
806










































808

PC 38:3

810
812




PC 38:2

814



SM, sphingomyelin; DHSM, dihydrosphingomyelin; PC, phosphatidylcholine.
*SM and DHSM cannot be rigorously differentiated in this experiment due to small sample
amounts. Assignment is based on natural occurrence. DHSM 24:1 is assigned based on its
prevalence as an ocular lipid.153
†Odd or ether-linked fatty acyl chain cannot be differentiated in this experiment.
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Previous in vitro studies have shown that lipid deposition is significantly
affected by contact lens material (see Section 1.3.5).129-131 In this in vivo study,
contact lens material was an important factor in lipid deposition, with both
polar (phospholipid) and non-polar (cholesterol) lipids depositing in larger
concentrations on senofilcon A contact lenses than balafilcon A lenses. Figure
3.3 highlights the effect of contact lens material on the concentration of lipids.
Senofilcon A contact lenses had a significantly greater concentration of total SM
than balafilcon A (78 ± 25 pmol/lens vs. 25 ± 3 pmol/lens; p < 0.05).
Furthermore, a number of individual short-chain SM molecules were also
observed at significantly higher concentrations in senofilcon A extracts,
including the most abundant SM 16:0 that alone constituted 44 ± 13 pmol/lens,
while there was no significant difference in longer-chained SM. A total PC
concentration of 257 ± 77 pmol/lens was observed in senofilcon A contact lens
extracts, which was significantly higher than balafilcon A contact lenses (25 ± 6
pmol/lens; p < 0.01). Five individual PC molecules were also observed at
significantly higher concentrations from senofilcon A extracts, with the highest
being PC 34:2 with a concentration of 92 ± 29 pmol/lens. Unlike SM, there does
not appear to be any bias on chain-length. Similar to the increased
concentration of polar lipids extracted from senofilcon A lenses, the non-polar
lipid, cholesterol, was also found to be more abundant in the senofilcon A
extracts. Figure 3.3C shows that 9.9 ± 2.2 µg of cholesterol was extracted from
senofilcon A contact lenses compared to only 3.9 ± 0.9 µg from worn balafilcon
A lenses (p < 0.05).

76

Figure 3.3: Concentration of A) Sphingomyelin and dihydrosphingomyelin; B)
phosphatidylcholine; and C) cholesterol extracted from balafilcon A and
senofilcon A contact lenses washed with a Polyquad, MAPD and tectronic 1304
wash solution. Data are presented as mean + S.E. ●p < 0.01; *p < 0.05. Balafilcon
A, n = 12; Senofilcon A, n = 8. SM, sphingomyelin; DHSM, dihydrosphingomyelin;
PC, phosphatidylcholine.
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Senofilcon A is an FDA (Food and Drug Administration, USA) group I material,
meaning it has low water content and a non-ionic polymer, while balafilcon A
contact lenses are an FDA group III contact lens, with low water content and an
ionic polymer. Previous studies have demonstrated that contact lenses
containing a non-ionic polymer show an increase in the deposition of lipids,
while those containing an ionic polymer deposit a larger concentration of
protein but a smaller concentration of lipid.24,

44, 45

Lipids are soluble in

pyrrolidone derivatives which are found in both contact lenses, with senofilcon
A containing PVP and balafilcon A containing N-vinyl pyrrolidone (NVP).174 The
deposition of tear film components onto contact lenses has been linked to a
large number of contact lens-related problems such as discomfort118 and
infection.119 A sound knowledge of the individual molecules deposited may
enable the manufacture of more suitable contact lenses or lens care solutions
that specifically target the removal of these molecules.

Lens care solutions are an important part of contact lens health and many
incorporate an antimicrobial agent, surfactant and buffer system into a
multipurpose solution. The efficacy of lipid removal by three commercially
available lens care solutions was tested here and the results indicated no
significant differences in the total concentration of either polar or non-polar
lipid deposits on balafilcon A lenses using any of the three washes (Figure 3.4).
Contact lenses soaked in solution C, however, contained significantly more SM
24:1 than both solution A (p < 0.05) and solution B (p < 0.01), and significantly
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more DHSM 24:1 (p < 0.01) compared to solution A, while lenses soaked in
solution B contained significantly more SM 16:0 than solution A (p < 0.05) and
significantly more PC 34:2 than solution C (p < 0.01).

While contact lens material-lens care solution combinations investigated in this
study revealed no significant difference, some combinations analysed by Zhao et
al. showed significantly higher deposition of proteins and cholesterol.136 The
variation in cholesterol concentration seen in this study may be due to the
differences in the method of analysis. Zhao et al. used TLC with quantification
by densitometry, as opposed to quantification using mass spectrometry with
internal standards described in this study. Perhaps co-eluting materials from
either the wash or contact lenses may give rise to uncertainty in the
densitometer reading in this case.
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Figure 3.4: Concentration of A) Sphingomyelin and dihydrosphingomyelin; B)
phosphatidylcholine; and C) cholesterol extracted from worn balafilcon A
contact lenses having been washed with commercial wash solutions with the
active ingredient: Solution A. Polyquad, MAPD and tectronic 1304; Solution B.
Alexidine poloxamer 407 and poloxamine 1107; and Solution C. Hydrogen
peroxide and Pluronic 17R4. Data are presented as mean + S.E. ●p < 0.01; *p <
0.05. Solution A, n = 12; solution B, n = 11, solution C, n = 10. SM, sphingomyelin;
DHSM, dihydrosphingomyelin; PC, phosphatidylcholine.
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Table 3.3 shows the abundance of total SM and PC molecules, normalised across
the phosphocholine lipids. These data reveal that in tears, phosphocholine lipids
are made up of approximately equal parts SM and PC molecules. This was also
reflected in the extracts from balafilcon A contact lenses soaked in solution A.
The concentration of PC was more than three times greater than SM in
senofilcon A contact lens extracts, while extracts from balafilcon A soaked in
solution C contained almost seven times the amount of SM to PC. This may
relate to the efficacy of the surfactant in removing PC over SM and may be
amplified in solution C by the effect of hydrogen peroxide on the significantly
more unsaturated PC molecules. Senofilcon A contact lenses soaked in solution
A showed a greater proportion of PC than SM, however it is unclear whether
this represents an affinity between the material and the PC class or the more
unsaturated fatty acid chains.
Table 3.3: Abundance of targeted lipid classes in tears and on contact lenses.
Sphingomyelin and phosphatidylcholine abundances normalised across
phosphocholine lipids. SM, sphingomyelin; PC, phosphatidylcholine.
Sample
Cholesterol
SM i
PCi

( SM i

PCi )

( SM i

PCi )

(µg/lens)

Tears (n = 6)

0.49 ± 0.02

0.51 ± 0.02

Not measured

Senofilcon A

0.23 ± 0.09

0.77 ± 0.30

10 ± 2

0.50 ± 0.12

0.50 ± 0.18

3.9 ± 0.9

0.63 ± 0.15

0.37 ± 0.16

6.3 ± 1.2

0.87 ± 0.39

0.13 ± 0.05

6.1 ± 1.5

Solution A (n = 8)
Balafilcon A
Solution A (n = 10)
Balafilcon A
Solution B (n = 11)
Balafilcon A
Solution C (n = 11)
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3. 4 Conclusions
The aim of this chapter was to determine the phospholipid composition of
human tears, examine the deposition of tear phospholipids and cholesterol onto
worn contact lenses and analyse the effect of lens material and lens care
solution. Specific observations included:
i.

A total of 23 distinct SM and PC molecules were identified in human
tears, with a similar molecular profile observed in worn contact lens
deposits.

ii. The concentration of representative polar and non-polar lipids deposited
onto contact lenses was significantly affected by contact lens material.
iii. While there were no significant differences in concentration with lens
care solutions, there was a differential efficacy in the removal of PC and
SM.

This chapter confirms the presence of phospholipids in human basal tears. For
the first time, a molecular profile of phosphocholine-containing lipids in tears
was observed, with a similar profile deposited onto contact lenses. The
significant differences in deposition between the two contact lens materials,
together with the differential efficacy of lens care solutions may be of
importance to eye care professionals to ensure the compatibility of lens
material and lens care solution in the removal of proteins and both polar and
non-polar lipids.
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4 IS

MEIBUM

THE

SOURCE

OF

TEAR

PHOSPHOLIPIDS?
Research described in this chapter has been published in:
Jennifer T. Saville, Zhenjun Zhao, Mark D.P. Willcox, Manjula A. Ariyavidana,
Stephen J. Blanksby, Todd W. Mitchell. (2011) Identification of phospholipids in
human meibum by nano-electrospray ionisation tandem mass spectrometry.
Experimental Eye Research. 92: 238-240

4. 1 Introduction
Research into the lipid composition of meibum first began in 1897175 where
cholesterol and fatty acids were identified. Since then, a variety of techniques
have been employed in an attempt to identify all lipid components. Despite this,
the small sample size and low abundance of some lipid classes has hampered
efforts and the complete lipidome has yet to be agreed on. Recent studies by
research groups such as Butovich and Green-Church and their respective coworkers39,

86-87, 89-90, 143, 176

have gone a long way to completing the meibum

lipidome with the confirmation of not only numerous classes of lipids but the
detection and identification of individual molecules within these classes.
Interestingly, however, while earlier studies utilising chromatography44,

51, 177

and mass spectrometry178-179 detected phospholipids in meibum they were not
identified in these latest studies and therefore their presence has been
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questioned.90, 102 Meibum is secreted via holocrine mechanism180 where the cell
ruptures and the cell membrane and its contents are released. Given the high
phospholipid content of cell membranes, it would be expected that some
phospholipid would be present. If it were true that meibum did not contain
phospholipid, it also raises the question as to the source of phospholipids
present in tears.105, 181

In this chapter a more comprehensive lipid analysis of tears is undertaken. The
presence of phospholipids in meibum is investigated and compared with the
lipid composition in tears.
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4. 2 Methods
4.2.1 Tear and meibum collection
Tears were collected from seven men and six women (mean age, 42 years) as
described previously (See Section 2.5.2). Meibum samples were collected from
the same volunteers (six males and two females; mean age, 45 years) by the
methods previously described (see Section 2.5.4). Lipid extraction of tear and
meibum samples were performed using the optimised methods in Section 2.5.5
and Chapter 2.5.7, respectively.

4.2.2 Mass spectrometry of lipid extracts
All samples were analysed by nanoESI-MS/MS on a Waters QuattroMicro™ QqQ
mass spectrometer (Manchester, UK) using the optimised methods described in
Section 2.5.8. Profiles of each lipid class were established by taking the percent
contribution of an individual lipid ion abundance to the total isotope sum of the
class (See Figure 2.12 in Section 2.3.5).

4.2.3 Statistics
Tear and meibum samples were analysed by one-way ANOVA and Students Ttest. All values are expressed as means ± S.E. and p values of < 0.05 were
considered statistically significant. All data were analysed using JMP 5.1 (SAS
Institutes, NC, USA).
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4. 3 Results and discussion
4.3.1 Cholesterol esters
Cholesterol esters have been reported as a major lipid component of meibum,36,
81, 177

with recent research by Chen et al. revealing CE accounts for more than

60% of total meibum lipids.86 In this study, targeted analysis of CEs was
achieved using a precursor ion scan for the protonated cholestadiene product
ion (m/z 369). Spectra from meibum and tear extracts (Figure 4.1) revealed 34
individual CE molecules, including a number of odd-chain molecules, the most
abundant of which was CE 25:0. There were also a number of CEs containing
very-long-chain fatty acids (i.e., those longer than 22 carbons), including both
saturated (e.g., CE 24:0 and CE 26:0), and unsaturated (e.g., CE 24:1 and CE
26:1). Figure 4.2 lists the CEs identified in tears and meibum, with their profile
shown as a percent contribution of individual CEs to the total CE isotope sum.

Nicolaides et al. analysed the fatty acid profile of meibum CEs by first separating
them by column chromatography, before saponification and derivitization of the
fatty acyl chains to allow analysis of the methyl esters by GC.36 They observed all
but one of the saturated CEs identified in this study (CE 29:0; 0.7% of total CE
observed in meibum). Monounsaturated CEs were only analysed by Nicolaides
et al. up to 26:1, with the four higher chain lengths detected in this study
equating to over 4% of the total CE observed in meibum. Of those analysed, all
but one were observed in meibum samples from both studies (CE 23:1; 0.1%
total CE observed in meibum). The only CE containing polyunsaturated fatty
86

acids reported by Nicolaides was CE 18:2 which they observed at 1.4% total CE.
In this study, 8 CEs with polyunsaturated fatty acyl chains were seen, although
they were all at a low abundance (each < 1% total CE).
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Figure 4.1: Positive precursor ion scan for cholesterol esters (m/z 369) from A)
a meibum lipid extract, and B) tear lipid extract.
Analysis of the profile as a percentage of total CE showed the profile of CEs was
similar between meibum and tears (Figure 4.2). Of the seven most abundant
species recently reported by Chen et al.86 six were also observed in high
abundance here, and of these five were also reported as the most abundant by
Nicolaides et al.36 The slight differences observed between studies may be due
to subject variability, differences in ethnicity, or differences in analysis
techniques and the range of species analysed, i.e., Nicolaides et al. only detected
fatty acids up to 29-carbons by GC, while Chen et al. only reported species up to
32-carbons long. With confirmation that these abundant CEs could be observed
with similar molecular profiles in both meibum and tears (and consistent with
previous reports), the next step was to analyse the more controversial presence
or absence of phospholipids.
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MEIBUM

TEARS

Figure 4.2: The profile of cholesterol ester (CE) molecules in meibum and tears, calculated as a percent of total CE. Data are
presented as the mean ± SE.

Cholesterol Ester profile (% total CE)

4.3.2 Phospholipids
The targeted analysis of phosphocholine-containing molecules in meibum lipid
extracts revealed a number of SM and PC ions (a typical mass spectrum is
shown in Figure 4.3A). The most abundant SM molecule observed was SM 16:0
(m/z 703), while the most abundant PCs were PC 34:1 (m/z 760) and PC 34:2
(m/z 758). The observation of the nominal mass at m/z 760 is consistent with
previous reports of LC-MS analysis of meibum,178-179 with the use of tandem
mass spectrometry in the present work providing unequivocal assignment of
the structure as a PC. A typical spectrum obtained from a tear lipid extract
(Figure 4.3B) contained the same molecular species to that observed in meibum,
but did reveal differences in the profile.
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Figure 4.3: Positive precursor ion scan for the phosphocholine head group (m/z
184) from A) a meibum lipid extract, and B) a tear lipid extract.

Based on these data, 22 SM molecules were identified in tears, with all but two
also identified in meibum (Table 4.1). The small sample size did not allow for
rigorous differentiation between SM and DHSM, with assignment based on
natural occurrence in ocular tissue.153 Twenty-eight PC molecules were
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observed in meibum, and 20 in tears (Table 4.2). Of those observed at a higher
relative abundance in meibum, a number have been tentatively identified (by
head group and nominal mass) as PCs with an ether-linked fatty acyl chain. It
could not, however, be ruled out that these molecules were diacyl PCs with one
odd fatty acyl chain, given the presence of odd chains in other tear lipids. Direct
confirmation of fatty acyl chains could not be obtained due to the low lipid
concentration, small volume and the complexity of the sample.

Table 4.1: Sphingomyelin (SM) molecules detected in tear and meibum extracts.
Lipid*
m/z [M + H]+
Tears
Meibum


SM 12:0
647


SM 13:0
661


SM 14:0
675


DHSM 14:0
677


SM 15:0
689


DHSM 15:0
691


SM 16:1
701


SM 16:0
703


DHSM 16:0
705


SM 17:0
717


DHSM 17:0
719

SM 18:1
729


SM 18:0
731

SM 20:1
757


SM 20:0
759


SM 22:1
785


SM 22:0
787


DHSM 22:0
789


SM 23:0
801


SM 24:2
811


SM 24:1
813
*DHSM 24:1


815
Only lipids with ion counts above the calculated LOD are included.
* SM and DHSM cannot be rigorously differentiated in this experiment because of the small
samples. Assignment is based on natural occurrence. DHSM 24:1 is assigned based on its
prevalence as an ocular lipid. 153
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Table 4.2: Phosphatidylcholine (PC) molecules detected in tear and meibum
extracts.
Lipid
m/z [M + H]+ Tears
Meibum

PC 26:0
650

PC 29:0
692


PC 30:0
706


PC O-32:1/PC 31:1
718


PC O-32:0/PC 31:0
720


PC 32:1
732


PC 32:0
734


PC O-34:2/PC 33:2
744


PC O-34:1/PC 33:1
746


PC O-34:0/PC 33:0
748

PC 34:3
756


PC 34:2
758


PC 34:1
760


PC 34:0
762


PC O-36:3/PC 35:3
770


PC O-36:2/PC 35:2
772


PC O-36:1/PC 35:1
774

PC O-36:0/PC 35:0
776


PC 36:4
782


PC 36:3
784


PC 36:2
786


PC 36:1
788


PC 36:0
790

PC O-38:1/PC 39:1
802


PC 38:6
806


PC 38:5
808


PC 38:4
810


PC 38:3
812


PC 38:2
814
While both samples contained similar molecular species, analysis of the profile
of SM molecules as a percentage of total SM revealed significant differences
(Figure 4.4). Although SM 16:0 made up ~35% of the total SM in both meibum
and tears, meibum was made up of a significantly higher percentage of SM’s
with shorter fatty acyl chains compared to tear samples. Levels of unsaturation
were also significantly different, with 83 ± 3% of meibum SM’s containing a
saturated fatty acyl chain, compared to 69 ± 1% in tears (p < 0.01).
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Figure 4.4: Profile of sphingomyelin molecules in meibum and tears, calculated
as a percentage of total SM. Data are presented as the mean ± SE. SM,
sphingomyelin; DHSM, dihydrosphingomyelin. * p < 0.05, • p < 0.01.
Analysis of PC profiles also revealed differences between meibum and tears
(Figure 4.5). The most prominent difference is seen in PC 32:2 which was more
than twice the proportion of PC in tears than in meibum. All five molecules that
were at a significantly higher percentage in tears were unsaturated. In fact,
analysis of the unsaturation of the fatty acyl chains in PC’s revealed that 90 ±
1% of tear PC’s were unsaturated, compared to 67 ± 2% in meibum. This may be
due to the significantly larger proportion of PC 34:2 in tear samples, as well as
the increased proportion of largely saturated ether-linked or odd chain species
in meibum. Earlier work showed that these ether-linked/odd chain species
were only observed in meibum,182 however an increase in instrument
sensitivity and an improved extraction efficiency allowed small amounts of
these molecules to be observed in tears.
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Figure 4.5: Profile of phoshatidylcholine (PC) molecules in meibum and tears, calculated as a percentage of total PC. Data are
presented as the mean ± SE. • p < 0.01.

Neutral loss scans were employed to determine the presence of any
Phosphatidylethanolamine (PE) molecules in meibum and tears. While previous
work did not identify any PE’s in either meibum or tears above the LOD, 181-182
the increased instrument sensitivity and extraction efficiency allowed a small
amount of PE to be identified in meibum, and a number of molecules were also
observed in tear extracts (Figure 4.6).
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Figure 4.6: Positive neutral loss scans for the phosphatidylethanolamine head
group (141 Da) for a A) tear lipid extract, and B) meibum extract.

Six PE molecules were identified in meibum, while 10 were identified in tear
samples (Table 4.3). One molecule that was only present in meibum was
tentatively identified (by head group and nominal mass) as a PE with an etherlinked fatty acyl chain (PE O-36:5; m/z 724), but a diacyl PE containing an odd
fatty acyl chain cannot be ruled out in this experiment. While there were a
greater number of molecules observed in tears, it is unclear from these data if
they are not present in meibum or simply below the LOD for the instrument.
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PEs were previously reported in meibum by Sullivan et al.178 and recent work
by Lam et al.183 identified 32 PE molecules in meibum, including all but three
molecules that were observed here (PE O-36:5, PE 38:3 and PE 40:7).

Table 4.3: Phosphatidylethanolamine (PE) molecules detected in tear and
meibum lipid extracts.
Lipid
m/z [M + H]+ Tears
Meibum


PE 34:2
716


PE 34:1
718

PE O-36:5/PE 35:5
724

PE 36:3
742


PE 36:2
744


PE 36:1
746

PE 38:6
764

PE 38:5
766


PE 38:4
768

PE 38:3
770

PE 40:7
790

One of the most relatively abundant PE lipids to be observed above the LOQ in
meibum was PE O-36:5, which was not observed in tears (Figure 4.7). The most
abundant molecule in tears was PE 36:2, which was observed at a significantly
larger proportion than in meibum (p < 0.01). Both PE 34:2 and PE 34:1 were
below the LOQ in meibum samples and therefore were significantly higher in
tears, while PE 36:3 was not observed above the LOD in meibum, but was found
to comprise 14% of total tear PE (p < 0.01). The large standard error observed
in the meibum data is likely due to ions in the scans being close to the LOQ of
the instrument.

95

meibum
40

tears

30
20
10
0
PE 40:7

PE 38:3

PE 38:4

PE 38:5

PE 38:6

PE 36:1

PE 36:2

PE 36:3

PE O-36:5/PE 35:5

PE 34:1

PE 34:2

Profile of phosphati dylethanolamine (% total PE)

50
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Neutral loss scans were also used to analyse the samples for phosphatidylserine
(PS) molecules (185 Da). The resulting spectra revealed that both tears and
meibum contained PS molecules (Figure 4.8), with four PS molecules identified
in meibum and 12 observed in tears (Table 4.4). PS molecules were detected in
rabbit meibum by Greiner et al.100 but were not reported in more recent studies
of human meibum.

96

788
100

790

A

PS IS

836

764
0

PS IS

764

100

B
790
788

732
0
700

m/z
720

740

760

780

800

820

840

Figure 4.8: Positive neutral loss scan for the phosphatidylserine head group
(185 Da) from A) a tear lipid extract and, B) a meibum extract.

Table 4.4: Phosphatidylserine (PS) molecules identified in tears and meibum.
Lipid*
m/z [M + H]+ Tears
Meibum

PS 32:2
732

PS 34:1
762


PS O-36:1/PS 35:1
776


PS 36:2
788


PS 36:1
790

PS 36:0
792

PS 38:4
812

PS 38:3
814

PS 38:2
816

PS 38:1
818

PS 40:6
836

PS 40:5
838

PS 40:4
840

The profile of PS was significantly different between the two samples, with the
abundant PS 32:2 (m/z 732) in observed in meibum, which was not present in
tears. A second molecule tentatively identified as PS O-36:1 (or possibly PS
35:1) was also observed in meibum and not in tears (m/z 776). Tear samples
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contained PS 36:2 and PS 36:1 at almost equal abundances, together accounting
for ~80% total PS. Tears also contained a number of PS lipids with longer chain
unsaturated fatty acyl chains, e.g., PS 38:3, PS 40:6 and PS 40:5.

Figure 4.9: Profile of phosphatidylserine (PS) molecules as a percentage of total
PS. Data are presented as the mean ± SE. • p < 0.01; * p < 0.05.

4.3.3 Quantification of phospholipids
The total concentration of phospholipids detected in tears was calculated at 17
± 1.9 pmol/mg tear. In meibum the total phospholipid was measured at 26 ± 8.1
pmol/mg meibum. Of this, the highest proportion of was made up of PC (Figure
4.10), with a concentration of 13 ± 4.5 pmol/mg of meibum, and 11 ± 3.5
pmol/mg of tears. SM in meibum was measured at 8.1 ± 2.9 pmol/mg of
meibum, while tears contained 6.2 ± 1.0 pmol/mg of tear. PS was calculated as
3.8 ± 1.5 pmol/mg of meibum, and 2.6 ± 0.5 pmol/mg of tears. PE contributed to
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the smallest proportion of total phospholipid in meibum with a concentration of
0.6 ± 0.5 pmol/mg meibum. A higher proportion of PE was observed in tears,
with a concentration of 2.6 ± 0.5 pmol/mg of tear. Despite the differences
observed in the pie charts shown in Figure 4.10, there was no significant
difference between tears and meibum in the contribution of each phospholipid
class to the total phospholipid concentration.

Given the lipid layer of the tear film has been estimated at 20 molecules thick15
and polar lipids account for only those closest to the aqueous phase, it is likely
that the phospholipid component detected here is not sufficient to have any
significant surfactant effect on meibum spreading.
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Figure 4.10: Mean contribution of classes to the concentration of total
phospholipid in A) tears, and B) meibum.

A large standard error was obtained when analysing the meibum samples.
While the small sample number (n = 5) is a factor, a relationship between
meibum sample mass and concentration was observed (Figure 4.11A). The
concentration of phospholipids in meibum (pmol/mg meibum) decreased as the
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mass of the sample increased. This could indicate that the phospholipids
detected in meibum come from the cell membrane surrounding the secretion or
it could be from contamination with tears or skin cells during sampling. A recent
study by Haworth et al. discussed differences in the lipid composition of
meibum when different sampling techniques were employed.184 They utilised
an inorganic phosphate assay to determine the presence of phospholipid in the
samples. They concluded that collection of meibum using a spatula, as was the
case in this study, yielded the lowest quantity of inorganic phosphates (which
includes phospholipids). While earlier studies detecting phospholipids have
been explained as contamination by Butovich,102 this recent study by Haworth
et al. also noted differences in inorganic phosphate between normal and dry eye
patients. This would suggest that, while not at concentrations sufficient to be
solely responsible for meibum spreading, phospholipids are not simply
contamination and may still play an important role in tear film stability.

Analysis of the relationship between tear sample mass and phospholipid
concentration did not result in the same trend (Figure 4.11B) with
concentration of phospholipids being independent of sample size. The reduction
in concentration seen in the larger samples (> 7 mg tear) in Figure 4.11B is
likely caused by stimulation of the tear during sampling, thus diluting the
sample.
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Figure 4.11: Trend between total mass of sample and concentration of
phosphocholine lipids in A) meibum and B) tears. Logarithmic trend lines are
used for both graphs.
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The work of Sullivan et al. using both direct infusion MS and prior fractionation
(HPLC) MS revealed a number of phospholipid molecules,178-179 while later
studies86,

90

did not. These discrepancies in the presence or absence of

phospholipids in meibum may be explained by their low concentration and the
complexity of the meibum sample, with sample preparation and instrument
conditions likely to impact on the spectra obtained. Spectra shown in later
studies86, 90 revealed a number of high abundance ions identified as WEs and
CEs. These molecules are observed over the same m/z range as phospholipids
and may therefore swamp the signals arising from low abundance
phospholipids (26 pmol/mg meibum). Furthermore, depending on the total
lipid concentration in the analyte solution, the presence of other abundant lipids
may result in suppression of phospholipid ionisation during the ESI process. 185
In this study, these potential problems were overcome by the use of targeted
scans (precursor ion and neutral loss scans), where phospholipids with a
particular structural motif can be extracted from the chemical noise and clearly
observed. The use of such scans has the added advantage of aiding in structural
confirmation due to their targeting of product ions particular to the class of
phospholipid being observed.

A further reason for discrepancy could be due to the ionisation method used in
some of the studies. Although Atmospheric Pressure Chemical Ionisation (APCI)
is a powerful technique in lipid analysis, it is more suited to non-polar lipid
classes (e.g., wax and cholesterol esters), and is thus less sensitive than ESI for
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the detection of phospholipids.186 Indeed, APCI has been shown to suppress the
ionisation of phospholipids, including PCs.187

The definitive identification of phospholipids in meibum shown here highlights
the need for a combination of techniques to enable optimised detection of such
a large range of structurally different classes of molecules in the complex milieu
of meibum. These results suggest that meibum may not be the sole source of
tear phospholipids, with further research needed into the role of sample
collection on the concentration of phospholipids in meibum.
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4. 4 Conclusions
The presence of phospholipids in human meibum has been a controversial topic
in literature over the last few years. In this study the presence of phospholipids
in meibum was analysed and compared to that already identified in tears.
Specific observations included:
i.

Phospholipids were detected in human meibum. Not only were
molecules from the previously analysed PC and SM classes
observed and quantified, but a number of PE and PS molecules
were also identified in both tears and meibum.

ii.

While most phospholipids identified in tears were also detected in
meibum, the profile of these molecules differed significantly, as did
the level of unsaturation.

iii.

A number of molecules tentatively identified as phospholipids with
an ether-linked fatty acyl chain were observed in meibum at a
higher relative abundance to those observed in tears.

iv.

The concentration of phospholipids in meibum may be dependent
on the sample size and method of collection.

This study confirms the presence of phospholipids in meibum, but suggests that
meibum may not be the sole source of phospholipids in tears. Furthermore, the
concentrations calculated here are not at levels sufficient for phospholipids to
play a major role in the spreading of non-polar lipids across the eye without the
help of another surfactant. Further work is needed to analyse the affect of
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sample collection on the presence and concentration of phospholipids in
meibum.
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5 CHANGES IN TEAR PHOSPHOLIPIDS WITH
CONTACT LENS WEAR
5. 1 Introduction
Contact lens-related dry eye and contact lens intolerance is a significant concern
for ophthalmic practitioners, with up to 50% of patients wearing contact lenses
presenting with symptoms of dry eye.60 The most common symptom of contact
lens-related dry eye is the feeling of dryness, with scratchiness and watery eyes
also regularly reported.188 Other symptoms include a decrease in visual acuity
and an increase in light sensitivity, and in some cases the severity is enough to
reduce or even cease wear.189 Despite the frequency of this disease, there are
inconsistencies between patient symptoms and clinical tests,189-190 with Nichols
et al. concluding that there was no significant correlation between dry eye
disease symptoms and many of the common clinical tests utilised.190 This
increases the difficulties faced by ophthalmic practitioners in the diagnosis and
management of the disease.

Insertion of a contact lens changes the homeostasis of the tear film by sitting
within the aqueous layer and splitting it into a pre- and post- contact lens tear
film (Figure 5.1).191 This leads to a thin film covering the surface of the contact
lens that still must protect the contact lens and eye from drying. 115 Clinical
observation has shown that there is an increase in the rate of tear film
evaporation during contact lens wear192-193 and that tear break-up times are
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significantly reduced compared to a normal pre-corneal tear film.194 These
changes may be the result of alterations in the molecular composition of the tear
film.

Figure 5.1: A schematic diagram of the tear film following contact lens insertion.
Adapted from Asbell and Uçkhan.195

At a biomolecular level, the concentration of total protein, lactoferrin, sIgA and
lysozyme are not significantly affected by contact lenses after six hours of
wear,196 with lactoferrin, lysozyme and albumin also observed at similar
concentrations after 6 months of extended wear.197 This suggests that the
proteins that are deposited onto contact lenses during wear (see chapter 3) are
quickly replaced within the tear film.

While proteins remain steady, other tear film components are altered by contact
lens wear. The concentration of tear mucins is lower in contact lens wearers
compared to non-wearing individuals.198 Alterations in tear lipids have also
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been observed, with cholesterol levels decreasing for up to 10 hours following
contact lens insertion before returning to normal levels.199 Analysis of tear
phospholipids by phosphorus assay suggested that there was a decrease in their
concentration after 12 hours of contact lens wear, with contact lens type being a
factor.200 There are, however, no studies on the effect of long term contact lens
wear on tear lipids. Given that 42% of wearers have a one month replacement
schedule,166 it is important to assess changes occurring over this time period.

In this chapter, the effect of contact lenses on tear phospholipids after 30 min
and 30 days of wear was analysed and compared to base levels (i.e., prior to
contact lens insertion). These results were correlated with a number of
subjective assessments undertaken at the time of tear sample collection.
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5. 2 Methods
5.2.1 Tear samples
Tear samples were collected using a capillary tube from 20 experienced contact
lens wearers (8 males and 12 females; mean age 36 years) prior to insertion of
either senofilcon A or balafilcon A contact lenses. After 30 minutes of wear, a
second tear sample was collected. Patients wore the lenses each day, removing
them each night and soaking them in a known commercially available cleaning
and disinfection solution. After 30 days, a third tear sample was collected before
contact lenses were removed. All samples were collected and stored as
described in Section 2.5.2. During the time of collection at both 30 min and 30
days, a number of subjective assessments were also made (Table 5.1).
Subjective ratings were given on a scale of 1 – 10, while subjective symptoms
were rated as none, mild, moderate and severe. All patients signed informed
consent prior to enrolment into the study, which was conducted in compliance
with the tenets of the Declaration of Helsinki and was approved by the Human
Ethics Review Panel of the Brien Holden Vision Institute.
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Table 5.1: Subjective assessments conducted at time of tear collection.

Assessment
Lens comfort
Stability of vision
Quality of vision
Dryness
Feeling of burning or stinging
Redness of eyes
Feeling of itching
Overall contact lens awareness

5.2.2 Lipid extraction from tears
Lipids were extracted from tear samples as described in Section 2.5.5.

5.2.3 Mass spectrometry of lipid extracts
All tear lipid extracts were analysed using a Waters QuattroMicro™ QqQ mass
spectrometer (Manchester, UK), as described in Section 2.5.8.

5.2.4 Statistical analysis
Tear volumes and phospholipid concentrations were analysed using JMP 5.1
(SAS Institutes, NC, USA) by a linear mixed model (Manova; repeated measures).
Significantly different results were then analysed with a paired T-test to
determine differences between means. All values are expressed as mean ± S.E.
and p < 0.05 was considered statistically significant. A sample point was
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considered an outlier if the concentration was more than two times the
standard deviation of the mean, and was not included in statistical analyses.

Correlations between phospholipid concentration and subjective assessments
were performed by Dr Thomas John Naduvilath from the Brien Holden Vision
Institute (Sydney, NSW, Australia). Data was analysed by a linear mixed model
with subject random intercepts. Additionally, correlation of subjective ratings
with lipid concentration was performed using Pearson's correlation. Statistical
significance was set at p < 0.05 and data are expressed as mean ± s.d.
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5. 3 Results
5.3.1 Tear sample size
Tear samples were collected by microcapillary and placed into pre-weighed
vials to enable their mass to be determined. Initial samples collected were 4.5 ±
0.5 mg for the balafilcon A group and 4.4 ± 0.8 mg for the senofilcon A group.
After 30 min of contact lens wear, the sample mass was 3.2 ± 0.4 mg for
balafilcon A and 3.9 ± 0.5 mg senofilcon A. Samples collected after 30 days
averaged 4.8 ± 0.9 mg for balafilcon A wearers, and 5 ± 0.5 mg for senofilcon A
patients. Although a decrease was observed after 30 min of wear (Figure 5.2),
the change in mass was not significant over time, nor were there any significant
differences between contact lens materials.

Mass of tear sample (mg)

6

balafilcon A
senofilcon A

4

2

0
Baseline
30 min
30 days
Figure 5.2: Mass of tear samples collected from patients prior to (baseline) and
following 30 min and 30 days of balafilcon A or senofilcon A contact lens wear.
Data are represented as mean + S.E.
112

5.3.2 Phospholipid concentrations
The concentration of phospholipids was measured prior to contact lens
insertion, 30 minutes following insertion and again after 30 days of wear. Table
5.2 contains the concentrations (means ± S.E.) of total phospholipid and the
individual classes for both balafilcon A and senofilcon A groups, together with
the combined data from all contact lens wearers at each time point. Initial
concentrations for both the balafilcon A and senofilcon A groups were similar,
and matched closely to those previously measured from non contact lenswearing individuals as described in Chapter 4. There were no significant
differences between contact lens groups after either short term (30 min) or long
term (30 days) wear. There were, however, differences in the concentration of
phospholipid classes over time. The concentration of SM was significantly lower
after 30 days compared to baseline (5 ± 0.5 pmol/mg tear v. 6 ± 1 pmol/mg tear,
respectively; p = 0.010). After 30 days, PS was also significantly lower (1 ± 0.5
pmol/mg tear) compared to both baseline (2 ± 0.5 pmol/mg tear; p = 0.002) and
30 min (2 ± 0.5 pmol/mg tear; p = 0.046). PE concentrations were higher at 30
min (3 ± 1 pmol/mg tear) compared to both baseline (2 ± 0.5 pmol/mg tear; p =
0.034) and 30 days (1 ± 0.5 pmol/mg tear; p = 0.022). Analysis of the interaction
between contact lens material and time revealed an increase in PC after 30 min
of balafilcon A wear compared to baseline (7 ± 1 pmol/mg tear v. 5 ± 1 pmol/mg
tear, respectively; p = 0.023). Those wearing senofilcon A contact lenses showed
a reduction in both PE (1 ± 0.5 pmol/mg tear v. 2 ± 0.5 pmol/mg tear; p = 0.045)
and total phospholipid concentrations (10 ± 1 pmol/mg tear v. 15 ± 2 pmol/mg
tear; p = 0.017) after 30 days of wear when compared to baseline levels.
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Table 5.2: Concentration of phospholipids in tears with balafilcon A and senofilcon A contact lens wear (pmol/mg tear).
Baseline
30 min
30 days
P value
Lipid

Bal

Sen

total

Bal

Sen

total

Bal

Sen

total

lens

time

Lens/time

Total PL

14 ± 2

15 ± 2

15 ± 1

20 ± 3

13 ± 3

16 ± 2

13 ± 1

10 ± 1*

11 ± 1

ns

ns

0.0140

SM

6±1

6±1

6±1

7±1

5±1

6±1

5±1

4 ± 0.5

5 ± 0.5*

ns

0.0461

ns

PC

5±1

5±1

5±1

7 ± 1*

5±1

6±1

5±1

4±1

5±1

ns

0.0418

0.0417

PE

2 ± 0.5

2 ± 0.5

2 ± 0.5

4±1

2±1

3 ± 1*†

1 ± 0.5

1 ± 0.5*

1 ± 0.5

ns

0.0257

0.0073

PS

2 ± 0.5

2 ± 0.5

2 ± 0.5

4±1

1±1

2 ± 0.5†

1 ± 0.5

1 ± 0.5

1 ± 0.5*

ns

0.0167

ns

Values are expressed as mean ± S.E. (n = 10 per group). Total, combined data from both contact lens groups; Bal, balafilcon A; sen,
senofilcon A; ns, not significant. * Significantly different from baseline. † Significantly different from 30 days.
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5.3.3 Subjective patient assessments
Patients were asked to make a number of subjective assessments after 30 min and
30 days of contact lens wear (listed in Table 5.1). These were primarily centred on
contact lens comfort and performance. Overall lens comfort was significantly lower
for balafilcon A compared to senofilcon A, both after 30 min (8.7 ± 1.4 v. 9.0 ± 1.2,
respectively; p = 0.040) and 30 days of wear (8.2 ± 1.4 v. 8.7 ± 1.2, respectively; p =
0.004). After 30 days of wear, overall lens awareness was given a significantly
lower rating for balafilcon A contact lenses compared to the senofilcon A group
(8.4 ± 1.3 v. 8.6 ± 1.1, respectively; p < 0.001). Comparison of subjective
assessments to phospholipid data revealed that there were no correlations
between contact lens comfort and performance and the concentration of tear
phospholipids.
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5. 4 Discussion
Contact lenses are known to affect the composition of the tear film, which has
implications for contact lens intolerance and contact lens-related dry eye. In this
study, the concentration of tear phospholipids was significantly altered by both
short and long term contact lens wear. Despite this, there were no correlations
between phospholipid concentrations and contact lens comfort and performance.

Phospholipid concentrations were influenced by the interaction between contact
lens material and time. Total phospholipid concentration was significantly lower
after 30 days of senofilcon A contact lens wear compared to baseline. One possible
explanation for this is the decrease in corneal sensitivity observed in patients
wearing senofilcon A contact lenses.201 A decrease in corneal sensitivity has been
linked with a reduction in the blink rate202 and may affect the turnover of tear
phospholipids deposited onto contact lenses.

The concentration of PC rose significantly after 30 mins of balafilcon A contact lens
wear, but returned to normal levels by 30 days. Balafilcon A has a much higher coefficient of friction than that of the cornea, i.e., the level of friction from the eyelid
travelling over the contact lens surface is much higher.203 This initial increase in PC
may be related to epithelial shearing of the eyelid before the tear film components
can properly coat the contact lens surface.

It is unclear from these results why all classes of phospholipid were not affected
equally. One likely explanation is the large variation in the concentration of lipids
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between individuals. Recent work by Dr Simon Brown (University of Wollongong,
data not published) has shown that the concentration of tear lipids vary greatly
between individuals. Analysis of samples from the same individual over
consecutive days revealed little variation in the concentration of the more
abundant lipids (i.e., CE, WE and OAHFAs) but a large variation in phospholipid
concentrations. This inter- and intra-subject variation may prevent the
observation of more subtle but still biologically significant changes in tear
phospholipids with contact lens wear.

There was no significant difference in the mass of tears collected by microcapillary,
suggesting little change in tear volume after either short term or long term contact
lens wear. This differs from Glasson et al., who determined that tear meniscus
height – a non-invasive measure of tear volume - was still increased after 6 hours
of contact lens wear,194 but agrees with an earlier study showing tear meniscus
height was similar between non-contact lens wearers and those who wore contact
lenses.204
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5. 5 Conclusions
The biocompatibility of contact lenses is vital to their success, however there is
limited research into their effect on tear lipids. This study has demonstrated that
insertion of a contact lens alters the concentration of phospholipids in tears with
both short and long term wear, but the changes are small and may not be clinically
significant. Given that phospholipids are not present in high enough
concentrations to act as the sole tear film surfactant (see Chapter 4), a future study
into the changes of the more abundant tear lipids, e.g. CEs and OAHFAs, and their
correlation to contact lens comfort would allow a more definitive analysis of tear
film lipid changes with contact lens wear. Given their recent link with dry eye
disease,183 OAHFAs may also play a crucial role in contact lens comfort and contact
lens-related dry eye and their correlation with ocular comfort should be assessed.
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6 APPLICATIONS OF MASS SPECTROMETRY IN
IDENTIFICATION OF NOVEL TEAR LIPIDS
Research described in this chapter is being prepared for publication in:
Jennifer T. Saville, Zhenjun Zhao, Mark D. P. Willcox, Naveen Kiran Dolla, Michael J.
Kelso, Todd W. Mitchell and Stephen J. Blanksby. (2013) Towards the complete
structural identification of (O-acyl)- -hydroxy fatty acids in human tears.

6. 1 Introduction
During our investigations into the phospholipid composition of human tears, a
number of ions were observed in negative ion ESI-MS that were not readily
classified as arising from the well known lipid classes. These ions appeared to be
part of a series, 28 Th apart (Figure 6.1).
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Figure 6.1: Negative ion ESI-MS spectrum of human tear lipid extract, showing
abundant ions that appear to be part of a series.
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Butovich et al.90 observed the same mass spectral pattern in human meibum
extracts using HPLC coupled with APCI-MS and noted that the retention time of
these molecules fell between wax esters and cholesterol.90 From retention time
and MS/MS data, they hypothesised that the ions were a series of molecules
containing two fatty acyl chains, a glycerol backbone and a negatively charged
head group, but could not fully identify the molecules. Further work by the same
group in 2009,89 again coupling HPLC with APCI-MS/MS, suggested that the ions
were in fact a new class of lipid called (O-acyl)- -hydroxy fatty acids (OAHFAs),
where an 18:1 fatty acyl chain is esterified to a long chain hydroxy fatty acid (HFA)
at the terminal hydroxyl group (Figure 6.2A). Long chain HFAs were first reported
in human and steer meibum by Nicolaides and Ruth in the early 1980’s. 145 After
saponification of the total lipid extract, they identified a group of primarily
unsaturated ω-HFA’s with chain lengths of between 30 and 36 carbons. Nicolaides
and Santos later identified ω-HFA’s in steer and human meibum to be components
of type I diesters, where the ω-HFA is esterified to another fatty acid and either a
sterol or possibly a fatty alcohol (Figure 6.2B). ω-HFAs were also determined to be
components of a series of triesters in steer meibum where further esterification
with either an α-HFA (type I; Figure 6.2C) or a 1,2-diol (type 2; Figure 6.2D)
occurred.146
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Figure 6.2: Putative structures of meibum lipids containing an ω-hydroxy fatty
acid (shown in blue). A) Structure proposed by Butovich et al. of the m/z 757 ion as
an OAHFA(18:1/32:1).89 B) Type I diester, C) Type I triester and D) Type II triester
molecules observed by Nicolaides and Santos.146

Since publication of the work by Butovich et al.,89 OAHFAs have been reported in
canine meibum using the same techniques,149 as well as in human meibum using
both ESI-MS86 and HPLC coupled with ESI-MS/MS. To date, there have been no
publications confirming their presence in tears, nor on their deposition onto
contact lenses. Furthermore, studies by Lam et al.183 revealed that the
concentration of a number of OAHFA molecules decreased with increasing dry eye
disease severity, suggesting that these molecules may have a major role in tear film
stability. Despite their potential importance, structural information has been
limited to accurate mass of the ionised molecules86 and MS/MS.89-90 While these
experiments provide insight into the elemental composition of the molecules and
some information on their connectivity, they do not answer questions on the
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presence or absence of hydroxyl groups, the position of the hydroxyl group on the
hydroxy fatty acid (if indeed there is one) and the position(s) of the double bonds.

6.1.1 Mass spectrometric techniques for structural elucidation
There are a number of mass spectrometric techniques that can be employed to aid
in the identification of molecular structure. High resolution instruments have the
ability to separate ions with the same nominal mass but different mono-isotopic
masses (Figure 6.3). The resolving power of an instrument is measured by taking
the mass of a singly charged ion, and dividing it by the width of that ion at 50% of
the peak height.156 In the example shown in Figure 6.3, a resolving power of ca.
7,000 is needed to separate the two peaks, below that and the ions are averaged as
one peak. High resolution mass spectrometers, such as Fourier-Transform Ion
Cyclotron Resonance (FT-ICR) and orbital ion trap mass spectrometers, have been
reported to have a resolving power of up to 500,000.205 High resolution is not only
important in observation of ions at a similar mass, but also facilitates high
precision mass measurements of ions of interest. Accurate mass experiments using
high resolution mass spectrometers allow the elemental composition of a molecule
to be determined with a high degree of certainty.206
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Figure 6.3: Simulated mass spectra for two phospholipids PS(18:1/16:1) and PE(O18:0/20:1) (m/z 760.5123 and m/z 760.6215, respectively). Low resolution
instruments do not have the resolving power to separate the two ions, instead
averaging them as one peak (left). While high resolution instruments enable the
detection of two distinct peaks (right).

While accurate mass experiments can assign the elemental composition of the
molecule, they do not give information on the molecular structure. A linear iontrap mass spectrometer enables ions of interest to be mass selected and subjected
to CID. One advantage of tandem mass spectrometry with this instrument over the
QqQ mass spectrometer (see Section 2.3.1) is the ability to repeat the cycle of
isolation and fragmentation multiple times to produce MSn spectra (Scheme 6.1).
This enables the fragmentation pattern and most likely structure of the molecule to
be determined.
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Scheme 6.1: The process of MSn experiments using a linear ion trap mass
spectrometer. A molecule is isolated and fragmented by CID. One of the product
ions is then isolated and further fragmented.

The position of the double bond on the fatty acyl chains of lipids can impact both
the structure and function of the molecule. The cis-9, trans-11 form of conjugated
linoleic acid (CLA; an 18:2 fatty acid), for example, has been linked with anticancer properties.207 The CLA isomer containing trans-10, cis-12 double bonds,
however, has been implicated in cardiovascular disease.208 Collision-induced
dissociation of many ionised lipids that differ only in the position of their double
bond produce identical product ions.209 Ozone induced dissociation (OzID) is a
technique developed by Thomas et al. that involves infusing ozone mixed with
helium buffer gas into the linear ion-trap where ions of the unsaturated lipid can
be trapped and allowed to react with the ozone.210 The reaction of ozone at the
carbon-carbon double bond cleaves the fatty acyl chain and produces distinct
fragments which can be used to determine double bond position (as illustrated in
Scheme 6.2).
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Scheme 6.2: Mechanism for the fragmentation of sodiated PC(16:0/18:1 n-9) ion
by reaction with ozone in a linear ion-trap mass spectrometer. Adapted from
Thomas et al.210

In this chapter, a suite of mass spectrometric techniques, including accurate mass,
tandem mass spectrometry, hydrogen deuterium exchange and OzID, have been
utilised to further interrogate the structure of putative OAHFA lipids in tears.
Furthermore, the presence of these molecules in tears, meibum and deposited onto
contact lenses was investigated.
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6. 2 Methods
6.2.1 Materials
Deuterated methanol (CH3OD; 99.5% purity), oleoyl chloride, 16-hydroxypalmitic
acid and 12-hydroxystearic acid were purchased from Sigma-Aldrich (Castle Hill,
NSW, Australia).

6.2.2 Tear and contact lens samples
All tear and contact lens samples were obtained from the Brien Holden Vision
Institute (Sydney, NSW, Australia) and prepared using the optimised methods in
Section 2.5.5 and Section 2.5.6, respectively.

6.2.3 Synthesis of an (O-oleoyl)-16-hydroxypalmitic acid standard
The synthesis of an (O-oleoyl)-16-hydroxypalmitic acid standard was performed
by Naveen Kiran Dolla (School of Chemistry, University of Wollongong) using the
following method. Oleoyl chloride (0.24 ml, 0.734 mmol) was added dropwise via
syringe to a stirring solution of 16-hydroxypalmitic acid (0.2g, 0.734 mmol) in
pyridine (5.0 mL) and the mixture was stirred at room temperature for 14-16 h.
Reaction progress was monitored by TLC (10% methanol/chloroform). Upon
completion of the reaction, the mixture was concentrated under reduced pressure
and the residue obtained was dissolved in chloroform (30 mL). The organic phase
was washed with water (3 x 15 mL) and saturated sodium chloride (15 mL) before
being dried over magnesium sulphate and concentrated under reduced pressure.
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Purification by column chromatography on silica gel (200-400 mesh) initially using
ethyl acetate:chloroform:hexane (4:1:1) followed by 3%-5% methanol:chloroform
as the eluent yielded the final compound (0.16 g; 41%) as a white, waxy solid.
1H

NMR (500 MHz , CDCl3): δ 5.34 (m, 2H, H8/H9), 4.05 (t, J = 6.5 Hz, 1H, H1’), 2.35

(t, J = 7.5 Hz, 2H, H1), 2.30 (t, J = 7.5 Hz, 1H, H1’), 2.08 (m, 4H, H7/H10), 1.61 (m, 4H,
H15’/H2’), 1.25-1.28 ( m, 46H, H3-6/H11-15/H3’-14’), 0.87 (t, J = 6.0 Hz, 3H, CH3);

13C

NMR (500MHz; CDCl3): δ 179 (COOH), 174 (COO), 129.7 (C9), 129.9 (C8), 64.0 (C1’),
31.9 (C1), 29.70 (C10), 29.76 (C7), 29.62 (C11), 29.64 (C6), 29.57 (C5), 29.52 (C12),
29.42 (C5’), 29.30 (C6’), 29.20 (C7’), 29.16 (C10’), 29.13 (C12’), 29.11 (C4), 29.06 (C13),
29.03 (C14), 27.25(C4’), 27.17 (C15), 27.15 (C2’), 25.9 (C3’), 25.0 (C2), 24.69 (C13),
24.67 (C14’), 22.67 (C16),14.09 (CH3). IR (CH2Cl2) ν max cm-1: 2924-2853, 1718,
1468, 1280; ESI-HRMS: calc for C34H65O4 [M+H]+ = 537.4902, experimental =
537.4877.

6.2.4 MSn experiments
MS/MS and MS3 of ions from tear extracts, as well as the authentic hydroxy fatty
acid and synthesised OAHFA standards were performed on an LTQ linear ion-trap
mass spectrometer (Thermo Fisher Scientific, San Jose, CA.). Tear samples were
analysed using a nanoESI source, while standards were analysed using direct
infusion ESI at a flow rate of 5 µL/min. Instrument parameters were optimised for
the ion at m/z 757 using the automatic tuning option with the only difference
being that when using nanoESI the capillary voltage was set to 1.5 kV, while in ESI
the capillary voltage was 5.0 kV. The isolation width was set to 1.0 Th and collision
energy was 40.0 arbitrary units for all experiments.
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6.2.5 Hydrogen-deuterium exchange
A contact lens lipid extract was dried down under nitrogen and reconstituted in
500 µL of CH3OD. The sample was analysed using a QuattroMicro™ QqQ mass
spectrometer (Waters, Manchester, UK), using the instrument parameters
discribed in Section 2.5.8. A precursor ion scan for the 17:0 fatty acyl chain (m/z
269) was obtained before and after reconstitution with deuterated methanol to
allow observation of the internal standards. A precursor ion scan for the 18:1 fatty
acyl chain (m/z 281) was obtained to detect the unknown lipids.

6.2.6 Accurate mass
Thermo Scientific LTQ FT-ICR
An LTQ linear ion trap mass spectrometer coupled with a 7T Fourier Transform
Ion Cyclotron Resonance (FT-ICR) mass analyser (Thermo Fisher Scientific,
Bremen, Germany) and a nanoESI source was used to analyse tear samples. Prior
to analysis, the instrument was calibrated with LTQ/FT-hybrid negative
calibration mix (calmix). Samples were analysed in negative ion mode, with the
instrument parameters optimised for the m/z 757 ion using the automatic tuning
option.

Waters Synapt HDMS
Tear samples were also analysed using a SYNAPT quadrupole time-of-flight mass
spectrometer (Waters, Manchester, UK) with a nanoESI source. The instrument
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was calibrated using sodium iodide (~ 1 mg/mL) and leucine enkephalin (1
mg/mL) was used as the reference compound for lock mass experiments (m/z
554.2615). A capillary voltage of -1.5 kV was applied, with a cone voltage of 5.0 kV
and a source temperature of 40 oC used.

Data analysis
All accurate mass data was analysed using the MassLynx 4.1 elemental
composition tool with a tolerance of 5 ppm and the elemental parameters as
follows: C, 10 – 100; H, 30 – 99; N, 0 – 3; O, 0 – 15; P, 0 – 2; S, 0 - 2.

6.2.7 Ozone induced dissociation
Ozone was generated using a HC-30 ozone generator (Ozone Solutions, Sioux
Center, IA, USA) at a concentration of 12% v/v in oxygen and collected in a
disposable syringe, as described by Thomas et al.210 Experiments were performed
using an LTQ linear ion-trap mass spectrometer (Thermo Fisher Scientific, San
Jose, CA.) that has been modified as described in Thomas et al.210 to allow infusion
of gases mixed with helium buffer gas into the ion trap. OzID experiments were
performed as described in Thomas et al.210 with the exception that a nanoESI
source was used. In brief, an isolation width of 2-3 Th was used to isolate the ions
of interest. The ions were trapped in the presence of ozone for up to 10 sec before
ejection for detection. Instrument parameters were as above in Section 5.2.3.
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6. 3 Results and discussion
Previous studies using positive ion ESI-MS/MS of lipid extracts from tears, meibum
and contact lenses have demonstrated that all three have a similar phospholipid
profile.181-182 Negative ion ESI-MS on tear lipid extracts (Figure 6.4B) revealed a
similar profile to that previously observed by Butovich et al.90 in meibum and
reproduced here (Figure 6.4A). MS scans of contact lens lipid extracts were
hampered by the presence of contact lens materials also extracted by the organic
solvent, however a precursor ion scan for the 18:1 fatty acyl chain (m/z 281)
contained the same series of ions (Figure 6.4C). A similar profile was observed in
precursor m/z 281 scans of meibum and tears. Due to their higher abundance,
most discussion here will concentrate on characterisation of the ions detected at
m/z 729, 757 and 785.
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Figure 6.4: Negative ion precursor ion scans for the 18:1 fatty acyl chain (m/z 281)
showing a similar profile in A) meibum, B) tear, and C) contact lens lipid extracts.

6.3.1 Accurate mass
Accurate mass experiments allow the elemental composition of an ion to be
determined with a high degree of certainty.206 Experiments using both the FT-ICR
and quadrupole time-of-flight mass spectrometers indicated the ions did not
contain phosphorus – ruling out phospholipids – but did match the composition
previously proposed by Butovich et al.89 with less than 3 ppm error (Table 6.1).
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Table 6.1: Accurate mass measurements of negative ions.
Synapt HDMS

m/z

Elemental

LTQ-FT

ppm m/z

composition

Elemental

ppm

composition

701.6431

C46H85O4

-2.4

701.64602 C46H85O4

1.7

703.6606

C46H87O4

0.3

703.66156 C46H87O4

1.7

727.6505* -

-

727.66123 C48H87O4

1.1

729.6768

C48H89O4

1.0

729.67707 C48H89O4

1.4

755.6912

C50H91O4

-0.7

755.69270 C50H91O4

1.3

757.7084

C50H93O4

1.3

757.70829 C50H93O4

1.2

785.7385

C52H97O4

-0.3

785.73980 C52H97O4

1.4

* No reasonable matches within the selection criteria.

Accurate mass MS/MS experiments were performed using the FT-ICR mass
spectrometer to obtain further structural information, with representative spectra
for the MS/MS of the three most abundant ions shown in Figure 6.5. All three
precursor ions gave rise to a product ion at m/z 281 which corresponds to an 18:1
fatty acyl chain. It should be noted that all ions analysed contained the same
abundant fatty acyl chain, which is in agreement with m/z 281 precursor ion scans.
Figure 6.5B also shows a product ion at m/z 493 from the m/z 757 ion which
returned an elemental composition of C32H61O3 with a mass accuracy of 1.0 ppm.
This indicates the ketene loss of the 18:1 fatty acyl chain, but does not provide any
further structural information. The product ion at m/z 475 suggests a loss of H2O
from the m/z 493 ion, however no reasonable matches were found within the
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selection criteria. Furthermore, there were product ions at a low relative
abundance (m/z 253 and m/z 521) that indicated the presence of molecules with
different fatty acyl chains, suggesting the presence of isomeric ions. This
observation was also noted by Butovich et al.89-90 and later by Chen et al86 and is
consistent with the presence of several compositional isomers.
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Figure 6.5: Negative ion nanoESI-MS/MS of A) m/z 729, B) m/z 757, and C) m/z
785.
Both MS/MS of m/z 729 and m/z 785 ions (Figure 6.5 A and C) also show the
ketene loss of the 18:1 fatty acyl chains (m/z 465 and m/z 521, respectively).
Furthermore, fragmentation of the m/z 729 ion revealed a low abundant product
ion for the 16:1 fatty acyl chain (m/z 253) and the corresponding ketene loss at
m/z 493. MS/MS of the m/z 785 ion revealed a 20:1 fatty acyl chain and
corresponding ketene loss (m/z 309 and m/z 503, respectively). An overview of
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the accurate mass of all product ions observed and their assigned elemental
composition is shown in Table 6.2. While this technique allows elemental
composition of ions and products to be determined, it does not give further insight
into the connectivity.

Table 6.2: Accurate mass of MS/MS product ions from LTQ-FT
Parent ion

Fragment m/z

m/z 729 →

493.46197

Elemental
composition
C32H61O3

465.43090

C30H57O3

0.2

281.24879

C18H33O2

2.5

521.49383

C34H65O3

0.8

493.46263

C32H61O3

1.0

475.53670

none

-

281.24892

C18H33O2

2.8

521.49358

C34H65O3

0.4

503.48274

C34H63O2

-0.2

281.24839

C18H33O2

1.1

m/z 757 →

m/z 785 →

ppm
-0.3

6.3.2 Hydrogen-deuterium exchange
The elemental composition points to the presence of four oxygen atoms in all
molecules in this series (See Table 6.1). To probe the presence or absence of
hydroxyl groups, hydrogen-deuterium exchange was utilised. A commercially
available phosphatidylglycerol (PG) internal standard was used to monitor the
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exchange. This phospholipid contains a glycerol head group that has two
exchangeable hydroxyl groups (See Figure 1.6 in Section 1.3.2). The spectra
obtained prior to (Figure 6.6A) and after (Figure 6.6B) reconstitution in deuterated
methanol showed that there was a 2 Da shift in mass of the PG ion corresponding
to the exchange of both hydroxyl hydrogens on the head group. There was,
however, no shift in mass of any of the tear molecules, indicating that they do not
contain any exchangeable hydrogen and excluding the possibility of hydroxyl
groups in these structures (Figure 6.6C).
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Figure 6.6: Hydrogen-deuterium exchange of worn contact lens extract. A)
Negative ion precursor ion scan for the 17:0 fatty acyl chain (m/z 273) prior to
exchange, showing the PG internal standard. B) Precursor ion scan following
reconstitution with deuterated methanol, showing 2 Da shift of PG standard. C)
Negative ion precursor ion scan for the 18:1 fatty acyl chain (m/z 281) showing no
shift in mass of the series of ions following hydrogen deuterium exchange. PG std,
phosphatidylglycerol standard.
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6.3.3 MSn of the hydroxy fatty acid chain
Further structural information was obtained by performing MS3 using a linear iontrap MS on the m/z 757 → m/z 493 product ion observed in Figure 6.5B. The
fragmentation pattern in the resulting spectrum (Figure 6.7A) indicated the loss of
H2O (- 16 Da), as well as two subsequent 28 Da losses with accurate mass data
(Table 6.2) indicating the loss of CO (m/z 447) and C2H4 (m/z 419). Further
indicative fragments could be observed 2 Da below the precursor and each of the
two major product ions. These can be attributed to dihydrogen loss and are
characteristic of alkoxide anion dissociation.211 This pattern was also observed in
MS3 of m/z 465, m/z 493, and m/z 521 product ions produced upon CID of the m/z
729 ion, indicating that the structures are related.

Analysis of the synthetic OAHFA(18:1/16:0) standard by MS/MS (spectrum not
shown) revealed a similar fragmentation pattern as seen with the m/z 757 ion
from the tear extract. The most abundant product ion in the spectrum was the 18:1
fatty acyl chain (m/z 281), with a second product ion at m/z 271 indicating the
ketene loss of the fatty acyl chain. An ion at low abundance indicating water loss
was also observed at m/z 253. MS3 of the m/z 535 → m/z 271 product ion revealed
a similar fragmentation pattern as that observed from the ionised lipid in the tear
extract (Figure 6.7B). If the structure suggested by Butovich89 is correct, the ketene
loss of the fatty acyl chain would leave the long chain hydroxy fatty acid, with this
fragmented in the MS3 experiments. An authentic ω-hydroxy fatty acid was
analysed by MS/MS and revealed the same fragmentation pattern as both the MS3
of the tear molecules and that of the synthesised OAHFA standard (Figure 6.7C).
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The proposed scheme for the fragmentation of the m/z 535 → m/z 271 ion is
shown in Scheme 6.3.

To further probe the position of the hydroxyl group, an authentic 12hydroxystearic acid was fragmented under the same conditions. The resulting
spectrum (Figure 6.7D) revealed that, while the fragmentation was similar, a
further product ion at m/z 169 was also observed. This is consistent with the
neutral loss of C6H13 which was not observed in the MS3 of the tear lipid and thus
indicates fragmentation at the site of hydroxylation. This result provides
supporting evidence that the position of the hydroxylation in the tear lipids is at
the ω-site.
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Figure 6.7: Negative ion CID spectrum of A) the m/z 757 → m/z 493 product ion
from a tear extract, revealing a similar fragmentation pattern to; B) MS3 of m/z 535
→ m/z 271 of a synthetic OAHFA (18:1/16:0) standard; C) MS/MS of an authentic
16-hydroxypalmitic acid standard, while D) shows a slightly different
fragmentation profile for an authentic 12-hydroxystearic acid.
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Scheme 6.3: Proposed fragmentation of 16-hydroxypalmitic acid upon collisioninduced dissociation.

6.3.4 Identification of double bond position using OzID
While the above experiments assist in establishing the most probable overall
structure of the molecule, they did not provide any evidence for the double bond
position on either the O-acyl chain or the HFA. To probe the double bond position
of the OAHFAs, OzID was used. OzID of the m/z 757 molecule (Figure 6.8) resulted
in a product ion at m/z 383, indicating a double bond is present nine bonds from
the ω-end (i.e., n-9) on the HFA 32:1 (from the hydroxyl end). A second product ion
28 Da higher is evidence of an n-7 double bond.210 This suggests that the molecule
contains a mixture of HFA(32:1 n-9) and HFA(32:1 n-7), with the n-9 position being
at a higher abundance. A second set of product ions were observed at a higher
mass, with a loss of 94 Da (m/z 663) from the parent ion indicative of an n-9
double bond on the O-acyl chain. Further evidence of the n-9 double bond can be
seen by the complementary aldehyde fragment at m/z 647. A small product ion
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was also observed at m/z 691, indicating there is also a small amount of the 18:1
fatty acyl chain with the double bond at the n-7 position. The suggested
fragmentation mechanism for the OzID of OAHFAs, using OAHFA(32:1 n-9/18:1 n9) as an example, is shown in Scheme 6.4.
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Figure 6.8: Negative ion OzID spectrum of m/z 757, showing double bond position
on both the hydroxy fatty acid (HFA) and O-acyl chain (OA).

Scheme 6.4: Proposed mechanism for the fragmentation of OAHFA(18:1 n-9/32:1
n-9) at m/z 757. NB, not all complementary ions were observed in the OzID
spectrum.
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These results suggest that the m/z 757 ion contains a mixture of OAHFA(18:1 n9/32:1 n-9), OAHFA(18:1 n-7/32:1 n-9), OAHFA(18:1 n-9/32:1 n-7) and
OAHFA(18:1 n-7/32:1 n-7), the structures shown in Figure 6.9. It should be noted
that these results do not account for the contribution of the isobaric ion
OAHFA(16:1/34:1), nor has the stereochemistry of the double bonds been
determined.

Figure 6.9: Structures of the possible isomers of the ions observed at m/z 757.

Reaction of the OAHFA(18:1/30:1) ion (m/z 729) with ozone resulted in fragments
consistent with a double bond at the n-9 (m/z 635; loss of 94 Da) and n-7 position
(m/z 663; loss of 66 Da) on the fatty acyl chain. Given that MS/MS experiments
indicated that several isobars were contributing to the m/z 729 ion population,
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this further complicated the spectrum. The m/z 355 ion is consistent with an n-9
double bond on the HFA of the OAHFA(18:1/30:1) molecule, but from this
spectrum we cannot rule out the appearance of an n-11 double bond on the HFA of
the OAHFA(16:1/32:1) molecule. The m/z 383 fragment is likely a combination of
n-7 on the HFA of the OAHFA(18:1/30:1) molecule and n-9 from the HFA of the
OAHFA(16:1/32:1) molecule. The m/z 411 fragment is attributed to a double bond
on the n-7 position of the HFA of OAHFA(16:1/32:1), but it cannot be ruled out that
there is also a small amount from an n-5 double bond on the HFA of
OAHFA(18:1/30:1).

Figure 6.10: Negative ion OzID spectrum of the m/z 729 ion, showing double bond
position on both the hydroxy fatty acid (HFA) and O-acyl chain (OA).

From this spectrum, there are 6 possible isomers for OAHFA(18:1/30:1) and six
for OAHFA(16:1/32:1), giving a total of 12 possible molecules at m/z 729 (Figure
6.11). Experiments using CID coupled with OzID were attempted to try and
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confirm double bond position for each of the HFA chain length (i.e., 30:1 and 32:1),
however the intensity of the fragments was too low to draw any conclusions.

Figure 6.11: Structures of the possible isomers of the ions observed at m/z 729.

Nicolaides et al. analysed double bond position of meibum lipids by first
saponifying a sample of steer meibum, before separation of the fatty acids from the
unsaponifiable constituents by column chromatography.147 Methyl esters of the
fatty acids were prepared before further chromatographic separation of the chain
types was performed. Ozonolysis was performed by bubbling an ozone/oxygen
mixture into a carbon disulfide solution of the fatty acid methyl ester to be
analysed. Samples and their ozonolysis products were then analysed by GC. Their
results indicated that 18:1 FAs are made up of 55% n-9, 40% n-7 and traces of both
n-5 and n-11 double bonds. The 16:1 FA was predominantly n-7 (77%), with 19%
n-5 and only 4% consisting of n-9 double bonds. It should be noted that these
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experiments analyse FAs and HFAs derived from all meibum lipids and not
individual lipid classes. Results shown in the OzID experiments completed here
suggest that the 18:1 FAs on OAHFAs are made up primarily of n-9 double bonds,
with the larger proportion of n-7 fragment in Figure 6.10 compared to Figure 6.8
likely being from the 16:1 FA of the isomeric OAHFA (16:1/32:1). For HFAs,
Nicolaides et al. concluded that HFA(32:1) was made up of 49% n-7 and 51% n-9,
while HFA(30:1) was determined to be predominantly n-7 (87%) with 13% having
a double bond at the n-9 position.147 OzID experiments suggest a higher proportion
of HFA(32:1 n-9) in OAHFAs, while HFA(30:1) has a higher proportion of n-9 than
seen in the total lipid.

6.3.5 Precursor ion scans for fatty acid chains
MS/MS data suggested lower abundance isomers with different fatty acyl chain
lengths attached. By utilising further precursor ion scans for fatty acid analysis in
negative ion mode, similar profiles were observed to those seen in Figure 6.1 for
OAHFAs containing a 16:1 (m/z 253) and 18:0 (m/z 283) fatty acyl chain (Figure
6.12B and C).
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Figure 6.12: Fatty acid precursor ion scans from a meibum lipid extract showing A)
the series of 18:1 OAHFAs (m/z 281), B) a similar series of ions with a 16:1 fatty
acyl chain (m/z 253), and C) an 18:0 fatty acyl chain (m/z 283).

The study described in Chapter 4 revealed that the concentration of phospholipids
in tears and meibum is too low to allow it to work effectively as a surfactant to
spread non-polar lipids across the aqueous surface of the tear film.181-182 Attention
has now turned to the role of OAHFAs in the maintenance of a stable tear film. Lam
et al. have recently shown that OAHFAs make up approximately 3.5% of the total
lipid content of meibum.183 The structure of these molecules suggests that they
may play an important role in the maintenance of a stable tear film. This could
have implications for dry eye disease and contact lens wear.
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6. 4 Conclusions
Recent papers on meibum lipids has shown much interest in the newly identified
OAHFAs,86,

89, 183

however little has been reported on the detailed structural

elucidation of these molecules. In this chapter a number of mass spectrometric
techniques were utilised which enabled the structure of these molecules to be
more rigorously investigated. Specific observations included:
i.

The series of OAHFAs was present in human tears, meibum and
deposited onto contact lenses. Furthermore, similar series of molecules
were observed with a 16:1 and an 18:0 fatty acyl chain.

ii.

The elemental composition of these lipid molecules matched the
proposed structure with less than 3 ppm error.

iii.

MS/MS and MS3 experiments to probe the position of the hydroxyl
group on the HFA support the suggestion that is it to be at the terminal
carbon.

iv.

The position of the double bond on both OA and HFA chains of specific
molecules could be determined using OzID and revealed the presence of
different isomers.

This study highlights the heterogeneity of this series of molecules, with OAHFAs
varying in not only chain length but also the double bond position of both the fatty
acyl chain and the hydroxy fatty acid. The structure of these molecules makes them
an attractive candidate to enable the spread of the non-polar tear film lipids across
the aqueous surface and would be an ideal target for future studies in tear film
stability and contact lens wear intolerance.
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7 CONCLUSIONS
The tear film, located on the anterior surface of the eye, is vital in ocular health and
vision. This film includes a thin outer layer of lipids that prevent excessive
evaporation of the aqueous phase that would result in tear film instability. The
complete lipidome of human tears has been difficult to determine due to both the
complexity and the small volume of the samples. Many studies have tried to
overcome this by using animal models or analysing meibum samples, but these
may not be a true representation of human tear lipids. In particular, the
identification of polar lipids – which act as a surfactant by spreading the more
abundant non-polar lipids across the surface of the eye – has been a source of
controversy. While earlier work established the presence of phospholipids in both
tears80, 98 and meibum,36, 44, 99-100 more recent studies have disputed this.90, 102-103
The first aim of this thesis was to determine the presence of phospholipids in
human tears.

The optimised methods developed in Chapter 2 allowed for the unequivocal
identification of SM, PC, PE and PS classes of phospholipids to a sum composition
level95 from individual basal tear samples (Chapter 4). Furthermore, the total
phospholipid concentration was determined to be 17 ± 2 pmol/mg tear. At these
low concentrations, it is unlikely that phospholipids play any significant role in the
spreading of the non-polar lipids across the aqueous phase, at least without
significant cooperative interactions with more abundant surfactants. This
surfactant effect may come from the recently observed lysophospholipids212 as
well as OAHFAs.
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Meibum is believed to be the major source of tear lipids, with one study revealing
many similarities between non-polar lipids in human tears and meibum.39 While
there is little dispute over the profile of non-polar lipids in meibum, there is much
debate on the polar lipids. Sullivan et al. identified a number of phospholipids
using LC-MS,178-179 however later mass spectrometric studies using APCI-MS90, 102103

and ESI-MS86 determined there were no appreciable amounts of phospholipid

in meibum. These inconsistencies are likely due to the small samples size (often
less than 1 mg) and also the complexity of the sample, with higher abundance
molecules masking the presence of these low level lipids. The second aim of this
thesis, therefore, was to evaluate the presence of phospholipids in human meibum
and to compare their profile to that of tears.

The methods that were optimised for tear phospholipid analysis could also be
employed to analyse meibum lipids. The study in Chapter 4 confirms the presence
of phospholipids in meibum, with the same phospholipid classes that were
identified in tears also observed in meibum. The results presented here have
recently been confirmed by Lam et al. using a similar technique.183 Further analysis
of the sum composition of the molecules within a class revealed a significantly
different profile in meibum compared to tears, suggesting that meibum is not the
sole source of tear phospholipids. This has implications for the use of meibum
samples to study the tear film, in particular in relation to polar lipids. The work
presented here also highlights the need for a combination of optimised techniques
to enable the identification of the large range of lipid classes in meibum.
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Contact lens intolerance is a common ophthalmic condition that has been linked
with changes in the tear film following insertion of a contact lens. Tear film
components deposit rapidly onto the lens and can lead to lens spoliation. The
profile and quantification of proteins deposited onto contact lenses has been well
documented,1, 120-122 but there is only limited information onto the deposition of
lipids. Furthermore, there has been little reported on the changes in tear film lipids
with contact lens wear. The third aim of this study was to determine if tear
phospholipids are deposited onto contact lenses in vivo and what effect contact
lens wear had on tear phospholipids.

Extraction of lipids from worn contact lenses presented its own challenges,
particularly in relation to the co-extraction of polymeric materials. The methods
developed in Chapter 2 allowed confirmation that both SM and PC classes of
phospholipids deposit onto contact lenses (Chapter 3). The concentration of both
polar and non-polar lipids deposited was significantly affected by contact lens
material, with a differential efficacy of lens care solutions in the removal of SM and
PC also observed. This expands on previous work by Carney et al. who saw similar
results by in vitro experiments.129 The work presented here highlights the
importance of ensuring compatible contact lenses and lens care solutions are
prescribed by ophthalmic practitioners.

Analysis of tear phospholipids following both short and long term contact lens
wear in Chapter 5 showed that their concentration was affected. For those changes
observed, short-term wear resulted in increased tear phospholipid concentrations,
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while long term wear (30 days) saw phospholipid levels decrease. Tear
phospholipids were not associated with contact lens comfort and performance,
with no correlation between tear phospholipid concentrations and any of the
subjective assessments patients were asked to make.

In conclusion, this thesis has presented optimised methods that have allowed the
identification and quantification of phospholipids in tears, meibum and deposited
onto contact lenses. This research demonstrates that tear film phospholipids are
not present at concentrations high enough to act as the sole surfactant in the
spread of non-polar lipids across the aqueous surface. Furthermore, tear
phospholipids are not associated with contact lens comfort or performance. This
work allows research to now turn to the newly characterised OAHFAs, which have
garnered much attention recently and have been implicated in dry eye disease.183
The work presented in Chapter 6 has provided the first step, with confirmation
that these molecules are present in meibum, tears and deposited into contact
lenses. Furthermore, the comprehensive structural characterisation undertaken
suggests that their properties make them ideal candidates to act as surfactants
within the tear film. This could have major implications for tear film stability, dry
eye disease and contact lens intolerance.
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